≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Alcoholic gastritis

DOID EFO Endpoint Browser PheWeb

K11_ALCGASTR

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K29.2
  • Hospital discharge: ICD-9 — 5353A
  • Cause of death: ICD-10 — K29.2
  • Cause of death: ICD-9 — 5353A

2 out of 7 registries used, show all original rules.

563

4. Check minimum number of events

None

563

5. Include endpoints

None

563

6. Filter based on genotype QC (FinnGen only)

547

Control definitions (FinnGen only)

Control exclude
K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K29
Name in latin
Gastritis acuta alcoholica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8819 1404 7278
Only index persons 5680 1039 4641
Unadjusted period prevalence (%)
Whole population 0.18 0.04 0.20
Only index persons 0.15 0.04 0.18
Median age at first event (years)
Whole population 45.44 47.43 44.92
Only index persons 45.25 47.33 44.79

-FinnGen-

Key figures

All Female Male
Number of individuals 547 117 430
Unadjusted period prevalence (%) 0.16 0.04 0.20
Median age at first event (years) 47.74 46.84 47.99

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
563
Matched controls
5630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
28.9
307.7
302
217
K29.2
ICD-10 Finland
Alcoholic gastritis
10806.6
307.7
400
*
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
33.2
258.3
179
78
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
56.0
224.4
130
30
5353A
ICD-9 Finland
Gastritis and duodenitis, Alcoholic gastritis
+∞
199.1
179
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
39.7
192.9
122
39
F10.20
ICD-10 Finland
Alcohol dependence currently independent
35.0
191.2
126
46
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
38.4
186.6
119
39
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
66.1
185.1
103
19
K92.0
ICD-10 Finland
Haematemesis
45.3
176.6
107
29
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
36.4
176.2
114
39
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
35.5
164.5
107
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
9.8
164.3
286
539
N05BA02
ATC
chlordiazepoxide; systemic
24.3
159.2
120
62
F10.24
ICD-10 Finland
Alcohol depence active use
34.3
158.3
104
37
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
49.8
156.1
92
22
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
42.8
137.5
84
23
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
40.4
133.8
83
24
F10.09
ICD-10 Finland
Alcohol intoxication UNS
23.0
132.4
101
53
N07BB01
ATC
disulfiram; oral
13.3
130.9
139
135
P15
ICPC
Chronic alcohol abuse
16.7
128.4
116
86
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
45.4
124.9
75
19
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
30.8
121.6
82
31
T36
ICD-10 Finland
Poisoning by systemic antibiotics
17.0
118.2
105
75
N05AB01
ATC
dixyrazine; systemic
33.1
114.3
75
26
N05BA01
ATC
diazepam; systemic, rectal
7.9
113.1
200
367
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
37.3
109.2
69
21
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
29.3
105.5
72
28
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
5.9
97.2
321
1040
N05CD07
ATC
temazepam; oral
7.1
95.0
178
342
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
17.0
94.0
82
56
N05CF01
ATC
zopiclone; oral
5.6
91.5
328
1126
K85
ICD-10 Finland
Acute pancreatitis
25.2
90.3
65
29
V03AA01, ,
ATC
19.5
89.2
72
42
N05AA02
ATC
levomepromazine; systemic
11.6
88.4
99
102
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
29.3
85.3
58
22
A02BA02
ATC
ranitidine; systemic
5.8
83.9
207
511
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
32.4
80.8
53
18
F32.9
ICD-10 Finland
Depressive episode, unspecified
6.8
76.8
142
265
N06AB04
ATC
citalopram; systemic
5.2
75.8
215
593
P16
ICPC
Acute alcohol abuse
18.7
75.7
62
37
R56.8
ICD-10 Finland
Other and unspecified convulsions
9.0
75.5
103
137
N06AX11
ATC
mirtazapine; oral
4.6
72.2
299
1103
Z72.1
ICD-10 Finland
Alcohol use
18.0
68.5
57
35
N05BA04
ATC
oxazepam; oral
4.6
67.8
240
780
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
10.5
66.4
78
85
N05AH04
ATC
quetiapine; oral
5.0
65.6
187
511
A02BC01
ATC
omeprazole; systemic
4.3
61.8
242
838
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
20.4
60.3
47
25
R10.1
ICD-10 Finland
Pain localized to upper abdomen
5.0
59.4
160
414
K92.1
ICD-10 Finland
Melaena
8.6
59.2
82
110
A02BC03
ATC
lansoprazole; oral
4.0
56.7
245
901
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
13.8
56.2
54
43
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.8
53.0
269
1094
N06AA12
ATC
doxepin; systemic
7.4
52.6
83
129
N06AB03
ATC
fluoxetine; oral
5.1
50.6
127
307
UJD02
NOMESCO Finland
Gastroscopy
11.8
50.2
53
49
A02BA03
ATC
famotidine; systemic
10.3
47.9
56
60
A02BC05
ATC
esomeprazole; systemic
3.5
47.5
289
1299
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.5
45.9
135
369
C07AA05
ATC
propranolol; systemic
4.0
45.3
168
544
S06.0
ICD-10 Finland
Concussion
4.9
44.9
115
281
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
13.2
44.9
44
36
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
89.4
44.6
49
6
K70.1
ICD-10 Finland
Alcoholic hepatitis
62.1
44.2
51
9
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
17.4
43.0
36
22
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.1
41.8
138
409
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
7.3
41.7
65
99
A06AD11
ATC
lactulose; oral
4.0
41.5
147
458
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
16.0
41.2
36
24
AA1AD
NOMESCO Finland
CT of head and brain
3.3
41.1
245
1067
N03AF01
ATC
carbamazepine; oral, rectal
6.1
41.1
77
142
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
40.7
175
621
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.6
40.2
179
650
N05AD03
ATC
melperone; systemic
13.5
39.5
38
30
5770D
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]
93.0
39.4
43
5
N05AF03
ATC
chlorprothixene; systemic
9.8
39.2
47
52
S01.0
ICD-10 Finland
Open wound of scalp
4.7
39.0
101
248
JN3AD
NOMESCO Finland
Abdominal CT examination
4.0
38.4
133
406
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
9.2
37.5
47
55
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
9.4
37.1
46
53
A02BA04
ATC
nizatidine; systemic
5.3
36.5
81
174
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.6
34.8
139
466
XF400
NOMESCO Finland
ECG with 12 standard connections
3.5
34.5
148
519
A02BC02
ATC
pantoprazole; systemic
3.4
34.0
440
2868
A10AB05
ATC
insulin aspart; parenteral
4.5
33.5
90
226
K20
ICD-10 Finland
Oesophagitis
67.7
33.5
38
6
R18
ICD-10 Finland
Ascites
9.9
33.0
39
42
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
43.0
32.6
40
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
32.5
223
1025
N06AA09
ATC
amitriptyline; systemic
4.5
31.9
85
212
R11
ICD-10 Finland
Nausea and vomiting
4.8
31.8
78
182
N02AX02
ATC
tramadol; systemic, rectal
2.8
30.8
319
1804
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
6.2
30.8
55
96
N06AX03
ATC
mianserin; oral
5.9
29.4
56
104
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
+∞
29.4
28
*
R10.0
ICD-10 Finland
Acute abdomen
7.5
29.2
43
61
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
10.9
29.1
32
31
R07.4
ICD-10 Finland
Chest pain, unspecified
2.8
29.1
211
989
N06AB06
ATC
sertraline; oral
4.0
28.7
92
263
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
32.9
28.5
37
12
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
28.4
103
321
K29.7
ICD-10 Finland
Gastritis, unspecified
29.0
28.4
38
14
NA1AD
NOMESCO Finland
Cervical spine CT examination
5.3
28.3
60
123
N03AX16
ATC
[U] pregabalin
2.9
28.1
172
734
K30
ICD-10 Finland
Functional dyspepsia
5.0
28.1
65
144
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.7
27.6
69
163
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.8
27.5
67
155
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.0
27.3
62
135
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.8
27.3
92
272
K29.1
ICD-10 Finland
Other acute gastritis
101.8
26.9
29
*
P01
ICPC
Feeling anxious/nervous/tense
4.6
26.7
68
163
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.8
26.2
89
264
K29.3
ICD-10 Finland
Chronic superficial gastritis
76.1
26.0
29
*
N05BE01
ATC
buspirone; oral
7.1
25.8
40
60
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.9
25.8
48
87
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
30.0
25.7
34
12
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.7
25.4
90
275
V03AB30, ,
ATC
27.7
25.2
34
13
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
24.8
25.1
35
15
N05CF02
ATC
zolpidem; oral
3.1
25.0
126
479
C03DA01
ATC
spironolactone; oral
3.2
24.8
116
422
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
24.7
171
772
W19
ICD-10 Finland
Unspecified fall
3.6
24.7
90
280
C03CA01
ATC
furosemide; systemic
2.6
24.6
223
1150
E87.6
ICD-10 Finland
Hypokalaemia
5.9
24.1
45
82
Z72.0
ICD-10 Finland
Tobacco use
7.2
23.6
36
53
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
8.7
23.3
30
36
A10AE04
ATC
insulin glargine; parenteral
3.3
23.3
98
334
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.5
23.2
60
145
N06AX16
ATC
venlafaxine; oral
3.3
23.2
99
340
WX892
NOMESCO Finland
Monitored bed care
3.7
23.1
81
245
X59
ICD-10 Finland
Exposure to unspecified factor
2.8
22.9
148
643
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.3
22.5
99
346
S22.3
ICD-10 Finland
Fracture of rib
3.7
22.5
80
244
T74.1
ICD-10 Finland
Physical abuse
9.4
22.2
27
30
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
18.0
22.1
34
20
K70.4
ICD-10 Finland
Alcoholic hepatic failure
65.2
22.0
25
*
2918A
ICD-9 Finland
Alcoholic psychoses, Other specified alcoholic psychosis
+∞
22.0
21
*
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
+∞
22.0
21
*
K22.1
ICD-10 Finland
Ulcer of oesophagus
119.7
21.7
23
*
N05AD01
ATC
haloperidol; systemic
6.2
21.6
38
65
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.6
21.6
54
127
P29
ICPC
Psychological sympt/compl other
4.6
21.1
52
121
K86.1
ICD-10 Finland
Other chronic pancreatitis
25.4
21.0
29
12
N06AB10
ATC
escitalopram; oral
2.8
21.0
130
549
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
21.0
91
315
P99
ICPC
Psychological disorders other
6.8
20.7
33
51
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.2
20.6
31
45
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.0
20.5
37
65
R53
ICD-10 Finland
Malaise and fatigue
2.5
20.4
160
759
E86
ICD-10 Finland
Volume depletion
6.7
20.3
33
52
N06AX05
ATC
trazodone; oral
7.3
20.1
30
43
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
6.0
20.0
36
63
SPAT1265
SPAT
Breathalyser
16.1
20.0
32
21
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
+∞
19.9
19
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
5.3
19.8
41
82
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.3
19.7
34
57
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
207.0
19.7
20
*
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.5
19.7
39
75
S70.0
ICD-10 Finland
Contusion of hip
5.4
19.4
39
76
Z2446
NOMESCO Finland
Social worker
4.0
19.3
58
157
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.0
19.3
59
162
J01DA01
ATC
[U] cefalexin
2.3
19.1
366
2522
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.4
19.1
74
238
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
+∞
18.9
18
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
18.8
141
652
N05BA12
ATC
alprazolam; oral
3.4
18.7
73
236
5770F
ICD-9 Finland
Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]
103.5
18.7
20
*
N07BA03
ATC
varenicline; oral
4.4
18.5
48
116
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
16.9
18.5
29
18
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
7.7
18.4
26
35
K85.2
ICD-10 Finland
Alcohol-induced acute pancreatitis
45.6
18.4
22
5
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
20.2
18.4
27
14
ZXD05
NOMESCO Finland
Urgent procedure
2.3
18.3
192
1031
SPAT1254
SPAT
Administration of medicine
2.9
18.1
97
378
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
17.3
18.0
28
17
F41.09
ICD-10 Finland
UNS Panic Syndrome
7.0
18.0
28
42
A01
ICPC
Pain general/multiple sites
3.3
18.0
74
247
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
7.2
18.0
27
39
K86.01
ICD-10 Finland
Late effects of pancreatitis caused by alcohol
185.6
17.6
18
*
S82.6
ICD-10 Finland
Fracture of lateral malleolus
3.9
17.6
55
153
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.8
17.6
56
158
K70.0
ICD-10 Finland
Alcoholic fatty liver
17.6
17.6
27
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
17.5
311
2051
N03AG01
ATC
valproic acid; systemic, rectal
4.1
17.5
51
135
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
19.4
17.5
26
14
R60.0
ICD-10 Finland
Localized oedema
2.9
17.5
89
337
R51.80
ICD-10 Finland
Headache
2.9
17.3
94
368
F05.9
ICD-10 Finland
Delirium, unspecified
6.0
17.3
31
54
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.3
17.3
69
226
M54.9
ICD-10 Finland
Dorsalgia, unspecified
3.0
17.1
83
306
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
16.9
118
525
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.9
16.6
37
79
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
6.4
16.5
28
46
A02BX02
ATC
sucralfate; oral
5.1
16.4
35
72
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
17.4
16.2
25
15
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.6
16.2
39
89
E87.2
ICD-10 Finland
Acidosis
25.4
16.1
22
9
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
25.4
16.1
22
9
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
6.4
16.1
27
44
S01.9
ICD-10 Finland
Open wound of head, part unspecified
5.9
16.0
29
51
N03AX09
ATC
lamotrigine; oral
5.2
15.9
33
66
S42.2
ICD-10 Finland
Fracture of upper end of humerus
4.7
15.9
38
86
2910A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal delirium
+∞
15.7
15
*
SPAT1240
SPAT
Therapeutic discussion
3.3
15.6
62
202
A03CA02
ATC
clidinium and psycholeptics; oral
4.0
15.4
46
124
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
29.5
15.3
20
7
F51.0
ICD-10 Finland
Nonorganic insomnia
2.6
15.3
97
411
A10AC01
ATC
insulin (human); parenteral
3.1
15.2
68
238
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
24.2
15.2
21
9
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
46.4
15.1
18
*
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
11.8
14.9
27
24
W10
ICD-10 Finland
Fall on and from stairs and steps
3.7
14.9
49
141
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
14.9
91
378
N05AH03
ATC
olanzapine; systemic
3.6
14.8
50
147
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
14.7
117
551
E87.5
ICD-10 Finland
Hyperkalaemia
6.8
14.6
23
35
P03
ICPC
Feeling depressed
3.5
14.5
52
159
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
23.0
14.3
20
9
N06AA06
ATC
trimipramine; systemic
5.9
14.3
26
46
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
6.6
14.2
23
36
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.5
14.2
52
161
T89
ICPC
Diabetes insulin dependent
4.2
14.1
39
99
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.3
14.0
54
173
53502
ICD-8 Finland
Gastritis and duodenitis, Gastritis acuta NUD
18.1
13.9
21
12
N05CD08
ATC
midazolam; nasal, systemic
5.5
13.8
27
51
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.5
13.8
34
79
N03AX12
ATC
[U] gabapentin; oral
2.4
13.6
105
487
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
16.7
13.5
21
13
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.3
13.5
23
38
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.6
13.5
46
136
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
6.5
13.4
22
35
N06AX21
ATC
duloxetine; oral
2.8
13.3
71
274
F34.1
ICD-10 Finland
Dysthymia
4.8
13.2
30
65
A46
ICD-10 Finland
Erysipelas
2.3
13.1
117
577
R07.3
ICD-10 Finland
Other chest pain
2.7
13.1
75
301
7803A
ICD-9 Finland
General symptoms, Convulsions
13.4
13.0
22
17
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
12.9
77
315
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
14.5
12.8
21
15
A41.9
ICD-10 Finland
Sepsis, unspecified
4.0
12.8
37
97
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.2
12.8
35
88
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
15.9
12.7
20
13
A10AE05
ATC
insulin detemir; parenteral
3.4
12.6
48
152
E16.19
ICD-10 Finland
Other specified hypoglycaemia
71.5
12.6
14
*
A04
ICPC
Weakness/tiredness general
2.5
12.6
86
376
J01MA12
ATC
levofloxacin; systemic
2.2
12.6
128
666
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
+∞
12.5
12
*
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
+∞
12.5
12
*
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
+∞
12.5
12
*
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
+∞
12.5
12
*
N05AX08
ATC
risperidone; systemic
2.9
12.5
64
242
J01FF01
ATC
clindamycin; systemic
2.0
12.3
165
952
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
12.3
193
1179
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
38.5
12.3
15
*
D10
ICPC
Vomiting
3.9
12.2
36
96
R95
ICPC
Chron obstructive pulmonary disease
4.1
12.2
34
87
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
12.2
88
395
D01
ICPC
Abdominal pain/cramps general
2.8
12.1
63
240
2913A
ICD-9 Finland
Alcoholic psychoses, Alcohol withdrawal hallucinosis
27.4
12.1
16
6
A03FA02
ATC
cisapride; oral, rectal
3.3
12.1
47
151
S92.3
ICD-10 Finland
Fracture of metatarsal bone
4.5
12.1
30
70
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
21.9
12.1
17
8
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
12.1
78
332
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
13.8
12.0
20
15
N06AB05
ATC
paroxetine; oral
3.5
12.0
43
131
SPAT1307
SPAT
Psychosocial counselling and guidance
4.5
11.8
29
67
A10AB01
ATC
insulin (human); parenteral
4.0
11.8
34
89
Z02.7
ICD-10 Finland
Issue of medical certificate
3.0
11.8
56
203
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.3
11.7
31
76
L28
ICPC
Limited function/disability (L)
2.2
11.7
111
560
F10
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol
66.4
11.6
13
*
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
23.5
11.6
16
7
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.4
11.6
42
129
5307A
ICD-9 Finland
Diseases of oesophagus, Gastrooesophageal laceration-haemorrhage syndrome
+∞
11.5
11
*
K29.8
ICD-10 Finland
Duodenitis
122.4
11.5
12
*
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
12.2
11.4
20
17
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
12.2
11.4
20
17
UJF32
NOMESCO Finland
Coloscopy
2.0
11.4
152
874
S22.4
ICD-10 Finland
Multiple fractures of ribs
4.9
11.3
25
53
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
11.3
48
163
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
25.6
11.2
15
6
SPAT1247
SPAT
Outpatient detoxication and monitoring
20.5
11.2
16
8
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
11.5
11.1
20
18
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.8
11.0
34
94
S00.8
ICD-10 Finland
Superficial injury of other parts of head
5.6
10.9
21
39
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
10.8
83
382
S00.0
ICD-10 Finland
Superficial injury of scalp
4.7
10.8
25
55
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
10.8
77
343
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
18.3
10.8
16
9
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
18.3
10.8
16
9
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
28.6
10.8
14
5
R03BB04
ATC
tiotropium bromide; inhalant
2.4
10.7
77
344
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
13.2
10.7
18
14
5780A
ICD-9 Finland
Gastro-intestinal haemorrhage, Haematemesis
61.2
10.7
12
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.3
10.7
85
398
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
4.1
10.6
29
73
D02
ICPC
Abdominal pain epigastric
3.6
10.5
35
102
P76
ICPC
Depressive disorder
3.4
10.5
38
117
K86.0
ICD-10 Finland
Alcohol-induced chronic pancreatitis
+∞
10.4
10
*
29120
ICD-8 Finland
Alcoholic psychosis, Other alcoholic hallucinosis
+∞
10.4
10
*
X58
ICD-10 Finland
Exposure to other specified factors
2.2
10.4
98
492
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
33.2
10.4
13
*
G72.8
ICD-10 Finland
Other specified myopathies
5.0
10.3
22
45
57708
ICD-8 Finland
Diseases of pancreas, Pancreatitis acuta alia
23.9
10.3
14
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
10.3
164
997
R06.0
ICD-10 Finland
Dyspnoea
1.9
10.2
158
951
H02AB06
ATC
prednisolone; systemic
1.8
10.2
270
1918
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
5.2
10.1
21
42
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.6
10.0
33
95
N06AX12
ATC
bupropion; oral
3.2
10.0
41
136
Z72.8
ICD-10 Finland
Other problems related to lifestyle
40.8
10.0
12
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
40.8
10.0
12
*
R41.0
ICD-10 Finland
Disorientation, unspecified
4.0
10.0
28
72
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
10.0
81
382
N05CD02
ATC
nitrazepam; oral
5.3
9.9
20
39
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
9.9
217
1454
R33
ICD-10 Finland
Retention of urine
2.4
9.9
71
317
N03AE01
ATC
clonazepam; systemic
3.2
9.9
40
132
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
9.9
165
1017
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
20.5
9.8
14
7
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
20.5
9.8
14
7
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.8
9.8
30
82
N02AA05
ATC
oxycodone; systemic
2.0
9.8
119
657
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.0
9.8
28
73
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
9.8
225
1528
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
9.8
98
504
A28
ICPC
Limited function/disability NOS
2.1
9.8
106
562
R02
ICPC
Shortness of breath/dyspnoea
2.3
9.7
81
386
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
13.7
9.7
16
12
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
9.7
54
213
Z72.2
ICD-10 Finland
Drug use
56.0
9.7
11
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
9.7
74
340
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.8
9.7
49
184
A69
ICPC
General and Unspecified, Other reason for encounter NEC
5.1
9.6
20
40
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.2
9.6
88
436
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.0
9.6
44
156
C07AB02
ATC
metoprolol; systemic
2.0
9.6
121
677
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
101.7
9.4
10
*
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
101.7
9.4
10
*
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
17.9
9.4
14
8
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
30.6
9.4
12
*
P19
ICPC
Drug abuse
30.6
9.4
12
*
D06
ICPC
Abdominal pain localized other
2.8
9.4
47
175
53509
ICD-8 Finland
Gastritis and duodenitis, Alia sive NUD
+∞
9.4
9
*
K22.2
ICD-10 Finland
Oesophageal obstruction
+∞
9.4
9
*
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
22.1
9.4
13
6
NH1AD
NOMESCO Finland
Ankle and foot CT
4.8
9.4
21
45
N30.0
ICD-10 Finland
Acute cystitis
2.4
9.4
68
305
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
9.3
55
224
IHZ05, ,
SPAT
4.3
9.3
24
58
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
9.2
32
96
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
3.2
9.1
37
122
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
4.9
9.1
20
42
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
11.7
9.1
16
14
M54.5
ICD-10 Finland
Low back pain
1.8
9.1
195
1292
D07AA02
ATC
hydrocortisone; topical
2.2
9.1
80
390
K59.09
ICD-10 Finland
Constipation, unspecified
2.9
9.1
42
150
9800A
ICD-9 Finland
Toxic effect of alcohol, Ethyl alcohol
37.3
9.0
11
*
K29.6
ICD-10 Finland
Other gastritis
37.3
9.0
11
*
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
37.3
9.0
11
*
E13.7
ICD-10 Finland
Other specified diabetes mellitus, with multiple complications
37.3
9.0
11
*
N02AC04
ATC
dextropropoxyphene; oral
3.6
9.0
30
87
EBA00
NOMESCO Finland
Extraction of tooth
1.8
9.0
209
1415
P01AB01
ATC
metronidazole; oral, rectal
1.8
9.0
198
1321
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
19.0
9.0
13
7
A98
ICPC
Health maint/preventive medicine
0.5
9.0
432
4860
30399
ICD-8 Finland
Other and unspecified alcoholism
24.5
8.9
12
5
Y07
ICD-10 Finland
Other maltreatment
12.8
8.9
15
12
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
12.8
8.9
15
12
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
4.6
8.9
21
47
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
5.0
8.9
19
39
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
8.9
77
373
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.0
8.8
117
665
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
3.4
8.8
32
99
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.4
8.7
31
94
NB6AA
NOMESCO Finland
Humerus X-ray examination
6.8
8.7
21
32
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
14.3
8.7
14
10
S02.30
ICD-10 Finland
Fracture of orbital floor, closed
7.8
8.7
19
25
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
8.7
156
978
R42
ICD-10 Finland
Dizziness and giddiness
1.9
8.6
127
747
B18.2
ICD-10 Finland
Chronic viral hepatitis C
8.4
8.6
18
22
ZXD35
NOMESCO Finland
Usual procedure
3.6
8.6
28
80
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
16.6
8.6
13
8
R52.9
ICD-10 Finland
Pain, unspecified
2.4
8.5
64
291
OAB43, ,
SPAT
0.4
8.5
35
879
R55
ICD-10 Finland
Syncope and collapse
2.3
8.5
69
325
N19
ICD-10 Finland
Unspecified kidney failure
3.4
8.5
31
96
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.6
8.4
20
45
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.7
8.4
26
72
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
+∞
8.4
8
*
5355X
ICD-9 Finland
Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis
+∞
8.4
8
*
Y91.1
ICD-10 Finland
Moderate alcohol intoxication
+∞
8.4
8
*
5710A
ICD-9 Finland
Chronic liver disease and cirrhosis, Alcoholic fatty liver
+∞
8.4
8
*
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
+∞
8.4
8
*
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.6
8.3
51
211
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
8.3
24
63
F60.9
ICD-10 Finland
Personality disorder, unspecified
9.7
8.3
16
17
S72.0
ICD-10 Finland
Fracture of neck of femur
3.5
8.3
29
87
30041
ICD-8 Finland
Neuroses, Depressiva
7.2
8.3
19
27
I20.09
ICD-10 Finland
Unstable angina
2.7
8.3
46
181
I50.0
ICD-10 Finland
Congestive heart failure
2.4
8.3
56
243
N05BB01
ATC
hydroxyzine; systemic
3.0
8.3
36
124
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
8.3
36
124
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
8.2
102
565
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
14.7
8.2
13
9
K59.0
ICD-10 Finland
Constipation
3.1
8.2
35
119
R4110
NOMESCO Finland
Physiotherapy
1.8
8.2
156
993
A03DA02
ATC
pitofenone and analgesics; systemic
7.0
8.1
19
28
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
8.1
35
120
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
8.1
95
516
K86.3
ICD-10 Finland
Pseudocyst of pancreas
17.5
8.1
12
7
F10.8
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders
33.9
8.1
10
*
Z94.4
ICD-10 Finland
Liver transplant status
33.9
8.1
10
*
C01DA14
ATC
isosorbide mononitrate; oral
2.0
8.1
99
546
P74
ICPC
Anxiety disorder/anxiety state
3.7
8.1
25
69
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
8.1
149
939
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
8.0
44
172
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
22.4
8.0
11
5
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
13.3
7.9
13
10
C07AB07
ATC
bisoprolol; oral
1.7
7.9
281
2115
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.2
7.9
21
52
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
7.8
68
329
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
11.0
7.8
14
13
F61.0
ICD-10 Finland
Mixed personality disorders
7.1
7.8
18
26
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.3
7.8
20
48
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.3
7.8
58
263
N06AB08
ATC
fluvoxamine; oral
4.0
7.8
22
57
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.0
7.8
22
57
R06AE07
ATC
cetirizine; oral
1.7
7.8
202
1400
X45
ICD-10 Finland
Accidental poisoning by and exposure to alcohol
15.3
7.7
12
8
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
7.7
37
135
J01EA01
ATC
trimethoprim; systemic
1.9
7.7
104
594
H02AB04
ATC
methylprednisolone; systemic
2.1
7.6
80
417
A07DA03
ATC
loperamide; oral
3.5
7.6
26
77
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
25.4
7.6
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
7.6
143
905
K05.31
ICD-10 Finland
Periodontitis pronounced
2.1
7.5
81
426
G44.2
ICD-10 Finland
Tension-type headache
2.2
7.5
64
307
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
7.5
155
1006
S20.2
ICD-10 Finland
Contusion of thorax
2.7
7.5
42
166
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.3
7.5
28
88
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.4
7.5
27
83
WX730
NOMESCO Finland
Conventional respirator
6.6
7.5
18
28
JN4BD
NOMESCO Finland
Extensive body CT
2.2
7.4
68
336
V03AA02, ,
ATC
81.1
7.4
8
*
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
81.1
7.4
8
*
E13.4
ICD-10 Finland
Other specified diabetes mellitus, with neurological complications
81.1
7.4
8
*
F10.04
ICD-10 Finland
Alcohol-related acute intoxication with hallucinations
81.1
7.4
8
*
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
7.4
97
547
30180
ICD-8 Finland
Personality disorders, Immatura
13.6
7.4
12
9
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
2.9
7.4
35
127
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
7.4
248
1831
D20
ICPC
Mouth/tongue/lip symptom/complaint
3.3
7.4
28
89
JDB10
NOMESCO Finland
Percutaneous gastrostomy
7.0
7.3
17
25
Z3231
NOMESCO Finland
Registered nurse
1.7
7.3
148
955
5350A
ICD-9 Finland
Gastritis and duodenitis, Acute gastritis
+∞
7.3
7
*
RS311, ,
NOMESCO Finland
+∞
7.3
7
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
7.3
7
*
5308A
ICD-9 Finland
Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]
+∞
7.3
7
*
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
+∞
7.3
7
*
6241
FHL
Fund application (Nissen)
+∞
7.3
7
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
7.3
18
29
R03BB01
ATC
ipratropium bromide; inhalant
3.2
7.3
29
95
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
16.0
7.3
11
7
F40.1
ICD-10 Finland
Social phobias
4.6
7.2
17
38
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.6
7.2
17
38
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
3.6
7.2
23
65
ZZA00
NOMESCO Finland
Split skin graft
3.5
7.2
24
70
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.4
7.2
26
80
F10.59
ICD-10 Finland
Alcohol psychosis, mixed type
30.4
7.2
9
*
H04AA01
ATC
glucagon; nasal, parenteral
6.7
7.2
17
26
K29.4
ICD-10 Finland
Chronic atrophic gastritis
20.3
7.2
10
5
F32.8
ICD-10 Finland
Other depressive episodes
8.1
7.1
15
19
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
8.1
7.1
15
19
R03AC02
ATC
salbutamol; inhalant
1.6
7.0
271
2060
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
7.0
54
248
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
4.0
7.0
20
52
SPAT1104
SPAT
Monitoring of emergency patient
2.6
7.0
39
154
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.5
7.0
17
27
R06.4
ICD-10 Finland
Hyperventilation
6.5
7.0
17
27
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.4
7.0
48
210
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.8
7.0
21
57
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
5.6
7.0
19
35
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
6.9
157
1043
PD5AD
NOMESCO Finland
CT of aorta
3.7
6.9
22
62
ZYY79, ,
SPAT
14.0
6.9
11
8
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.2
6.9
18
44
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.2
6.9
18
44
NGJ60
NOMESCO Finland
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
8.4
6.9
14
17
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
8.4
6.9
14
17
S06.3
ICD-10 Finland
Focal brain injury
6.2
6.8
17
28
SPAT1227
SPAT
Substance abuse rehabilitation
9.5
6.8
13
14
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.9
6.8
31
110
SPAT1234
SPAT
Support of social functional capacity
2.9
6.8
31
110
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
4.4
6.8
17
40
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
4.4
6.8
17
40
R25.1
ICD-10 Finland
Tremor, unspecified
3.6
6.8
22
63
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
6.8
52
239
79301
ICD-8 Finland
Observation, without need for further medical care, Observatio post tentationem suicidii
40.6
6.8
8
*
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
40.6
6.8
8
*
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
16.9
6.8
10
6
J01DB01
ATC
cefalexin; oral
1.7
6.7
440
3790
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
6.7
55
260
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.7
213
1542
Z00.0
ICD-10 Finland
General medical examination
1.8
6.7
106
635
A11
ICPC
Chest pain NOS
2.3
6.7
51
234
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.2
6.7
26
84
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.1
6.7
18
45
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
6.7
106
636
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
6.6
21
59
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.6
190
1339
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prosthodontic work
2.9
6.6
30
106
N03AX14
ATC
levetiracetam; systemic
3.5
6.6
22
64
A10AB04
ATC
insulin lispro; parenteral
3.4
6.6
23
69
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
6.6
78
424
P18
ICPC
Medication abuse
12.4
6.6
11
9
S42.0
ICD-10 Finland
Fracture of clavicle
3.1
6.6
27
90
R12
ICD-10 Finland
Heartburn
2.6
6.6
38
153
S06.2
ICD-10 Finland
Diffuse brain injury
10.2
6.6
12
12
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.2
6.6
58
283
P06
ICPC
Sleep disturbance
2.0
6.5
71
375
N06AG02
ATC
moclobemide; oral
3.0
6.5
28
96
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.2
6.5
25
80
R13
ICD-10 Finland
Dysphagia
2.6
6.5
38
154
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
5.8
6.5
17
30
P17
ICPC
Tobacco abuse
7.5
6.4
14
19
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
70.6
6.4
7
*
E14.1
ICD-10 Finland
Unspecified diabetes mellitus, with ketoacidosis
70.6
6.4
7
*
9663A
ICD-9 Finland
Poisoning by anticonvulsants and anti-Parkinsonism drugs, Other and unspecified anticonvulsants[MYRKYTYS:KARBAMATSEPIINI]
70.6
6.4
7
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
3.8
6.4
19
51
M10.9
ICD-10 Finland
Gout, unspecified
2.2
6.4
55
265
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.4
105
635
G81.9
ICD-10 Finland
Hemiplegia, unspecified
8.3
6.4
13
16
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
6.4
69
364
D06AX01
ATC
fusidic acid; topical
2.2
6.4
51
239
N05AB03
ATC
perphenazine; systemic, rectal
3.3
6.3
23
71
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.5
6.3
21
61
-1, ,
NOMESCO Finland
1.7
6.3
159
1082
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
6.1
6.3
16
27
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
6.3
77
423
A07AA02
ATC
nystatin; oral
2.9
6.3
30
109
M79.6
ICD-10 Finland
Pain in limb
1.6
6.3
213
1559
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
18.3
6.3
9
5
SPAT1241
SPAT
Extensive assessment of psychosocial situation
18.3
6.3
9
5
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
18.3
6.3
9
5
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
+∞
6.3
6
*
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
+∞
6.3
6
*
B37
ICD-10 Finland
Candidiasis
+∞
6.3
6
*
K10.3
ICD-10 Finland
Alveolitis of jaws
2.9
6.2
29
104
IAB10
NOMESCO Finland
Psychiatric consultation concerning substance abuse
27.0
6.2
8
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.2
6.2
24
77
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
6.2
51
241
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
4.0
6.2
17
43
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.8
6.2
16
28
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
6.2
34
134
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.1
6.1
25
83
R07.2
ICD-10 Finland
Precordial pain
4.2
6.1
16
39
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.2
6.1
16
39
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
6.1
30
111
Y34
ICD-10 Finland
Unspecified event, undetermined intent
12.7
6.1
10
8
SPAT1284
SPAT
Extensive health certificate
3.7
6.1
19
53
N05AX12
ATC
aripiprazole; systemic
3.3
6.1
22
68
ZXD00
NOMESCO Finland
Emergency procedure
3.5
6.1
20
58
L76
ICPC
Fracture: other
3.5
6.1
20
58
SPD01
NOMESCO Finland
Mucosa-supported complete denture
6.1
6.0
15
25
N02BF02
ATC
pregabalin; oral
2.5
6.0
37
154

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Other and unspecified abdominal pain
R10.4 [45568113]
2.1e+00
2.8e+00
3.1e+00
1.0e+50
3.1e+00
3.0e+00
2.6e+00
cases:11.75%
controls:1.66%
cases:8.02%
controls:0.51%
cases:3.36%
controls:0.15%
cases:4.66%
controls:0.00%
cases:2.09%
controls:0.09%
cases:9.46%
controls:0.53%
cases:20.37%
controls:1.79%
63
88
473
5201
43
27
493
5262
18
8
518
5281
25
0
511
5289
11
5
515
5284
49
28
469
5239
99
90
387
4929
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
3.5e+00
4.0e+00
—
1.0e+50
—
4.3e+00
3.9e+00
cases:15.49%
controls:0.57%
cases:9.70%
controls:0.19%
—
—
cases:5.22%
controls:0.00%
—
—
cases:11.39%
controls:0.17%
cases:21.60%
controls:0.58%
83
30
453
5259
52
10
484
5279
—
28
0
508
5289
—
59
9
459
5258
105
29
381
4990
General Practice
1 [38004446]
1.9e+00
2.3e+00
3.1e+00
1.0e+50
2.9e+00
2.4e+00
2.0e+00
cases:23.13%
controls:4.22%
cases:15.11%
controls:1.68%
cases:4.29%
controls:0.21%
cases:10.82%
controls:0.00%
cases:5.32%
controls:0.32%
cases:17.95%
controls:1.92%
cases:37.86%
controls:7.59%
124
223
412
5066
81
89
455
5200
23
11
513
5278
58
0
478
5289
28
17
498
5272
93
101
425
5166
184
381
302
4638
Upper gastrointestinal surgery
106 [44777669]
1.5e+00
2.2e+00
2.7e+00
—
3.6e+00
2.4e+00
2.0e+00
cases:10.07%
controls:2.33%
cases:7.09%
controls:0.85%
cases:1.87%
controls:0.13%
—
—
cases:4.56%
controls:0.13%
cases:10.23%
controls:1.03%
cases:22.22%
controls:3.73%
54
123
482
5166
38
45
498
5244
10
7
526
5282
—
24
7
502
5282
53
54
465
5213
108
187
378
4832
disulfiram; oral
N07BB01 [21604821]
3.2e+00
4.1e+00
—
—
1.0e+50
3.2e+00
3.1e+00
cases:9.51%
controls:0.43%
cases:5.41%
controls:0.09%
—
—
—
—
cases:0.95%
controls:0.00%
cases:5.02%
controls:0.21%
cases:13.37%
controls:0.66%
51
23
485
5266
29
5
507
5284
—
—
5
0
521
5289
26
11
492
5256
65
33
421
4986
Psychiatry
26 [38004469]
2.3e+00
2.0e+00
2.1e+00
—
2.5e+00
2.3e+00
2.5e+00
cases:19.40%
controls:2.42%
cases:8.58%
controls:1.27%
cases:3.73%
controls:0.47%
—
—
cases:5.32%
controls:0.47%
cases:11.78%
controls:1.29%
cases:26.75%
controls:2.95%
104
128
432
5161
46
67
490
5222
20
25
516
5264
—
28
25
498
5264
61
68
457
5199
130
148
356
4871
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.8e+00
2.0e+00
2.5e+00
—
2.9e+00
2.0e+00
2.3e+00
cases:10.45%
controls:1.93%
cases:6.72%
controls:0.95%
cases:2.24%
controls:0.19%
—
—
cases:3.42%
controls:0.19%
cases:7.34%
controls:1.03%
cases:16.26%
controls:1.93%
56
102
480
5187
36
50
500
5239
12
10
524
5279
—
18
10
508
5279
38
54
480
5213
79
97
407
4922
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
1.2e+00
2.1e+00
3.0e+00
1.0e+50
3.4e+00
2.2e+00
1.5e+00
cases:6.34%
controls:2.04%
cases:7.65%
controls:1.02%
cases:3.36%
controls:0.17%
cases:5.41%
controls:0.00%
cases:4.37%
controls:0.15%
cases:8.88%
controls:1.04%
cases:13.99%
controls:3.35%
34
108
502
5181
41
54
495
5235
18
9
518
5280
29
0
507
5289
23
8
503
5281
46
55
472
5212
68
168
418
4851
spironolactone; oral
C03DA01 [21601534]
1.7e+00
2.2e+00
2.5e+00
—
2.4e+00
2.5e+00
1.6e+00
cases:2.61%
controls:0.49%
cases:3.36%
controls:0.40%
cases:1.12%
controls:0.09%
—
—
cases:2.47%
controls:0.23%
cases:5.02%
controls:0.44%
cases:5.14%
controls:1.08%
14
26
522
5263
18
21
518
5268
6
5
530
5284
—
13
12
513
5277
26
23
492
5244
25
54
461
4965
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
3.0e+00
2.9e+00
1.0e+50
1.0e+50
—
3.8e+00
2.7e+00
cases:9.14%
controls:0.49%
cases:2.61%
controls:0.15%
cases:0.93%
controls:0.00%
cases:9.89%
controls:0.00%
—
—
cases:7.53%
controls:0.19%
cases:11.11%
controls:0.86%
49
26
487
5263
14
8
522
5281
5
0
531
5289
53
0
483
5289
—
39
10
479
5257
54
43
432
4976
Emergency Room Visit
ER [9203]
1.2e+00
1.9e+00
3.0e+00
—
2.7e+00
2.1e+00
1.4e+00
cases:38.06%
controls:15.45%
cases:27.43%
controls:5.28%
cases:11.38%
controls:0.64%
—
—
cases:9.32%
controls:0.72%
cases:33.20%
controls:5.96%
cases:52.26%
controls:20.56%
204
817
332
4472
147
279
389
5010
61
34
475
5255
—
49
38
477
5251
172
314
346
4953
254
1032
232
3987
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1.1e+00
1.6e+00
2.9e+00
—
3.0e+00
1.9e+00
1.4e+00
cases:4.85%
controls:1.68%
cases:4.66%
controls:1.02%
cases:2.80%
controls:0.15%
—
—
cases:2.66%
controls:0.13%
cases:5.79%
controls:0.89%
cases:9.47%
controls:2.55%
26
89
510
5200
25
54
511
5235
15
8
521
5281
—
14
7
512
5282
30
47
488
5220
46
128
440
4891
Internal Medicine
11 [38004456]
1.5e+00
1.9e+00
2.3e+00
—
2.6e+00
1.7e+00
1.8e+00
cases:41.60%
controls:13.20%
cases:27.24%
controls:5.33%
cases:7.09%
controls:0.78%
—
—
cases:9.89%
controls:0.79%
cases:27.61%
controls:6.46%
cases:53.29%
controls:16.22%
223
698
313
4591
146
282
390
5007
38
41
498
5248
—
52
42
474
5247
143
340
375
4927
259
814
227
4205
propranolol; oral, parenteral
C07AA05 [21601670]
1.6e+00
1.8e+00
2.0e+00
—
2.4e+00
2.2e+00
1.8e+00
cases:7.28%
controls:1.59%
cases:4.48%
controls:0.79%
cases:1.12%
controls:0.15%
—
—
cases:2.28%
controls:0.21%
cases:7.34%
controls:0.87%
cases:10.49%
controls:1.85%
39
84
497
5205
24
42
512
5247
6
8
530
5281
—
12
11
514
5278
38
46
480
5221
51
93
435
4926
fluoxetine; oral
N06AB03 [21604711]
1.6e+00
2.0e+00
2.5e+00
—
2.0e+00
2.1e+00
1.6e+00
cases:6.16%
controls:1.29%
cases:4.10%
controls:0.57%
cases:1.31%
controls:0.11%
—
—
cases:1.14%
controls:0.15%
cases:4.44%
controls:0.57%
cases:6.79%
controls:1.47%
33
68
503
5221
22
30
514
5259
7
6
529
5283
—
6
8
520
5281
23
30
495
5237
33
74
453
4945
Gastroenterology
10 [38004455]
1.8e+00
2.0e+00
—
1.0e+50
3.4e+00
2.5e+00
1.9e+00
cases:5.41%
controls:0.95%
cases:3.36%
controls:0.47%
—
—
cases:5.60%
controls:0.00%
cases:2.85%
controls:0.09%
cases:5.21%
controls:0.44%
cases:9.47%
controls:1.51%
29
50
507
5239
18
25
518
5264
—
30
0
506
5289
15
5
511
5284
27
23
491
5244
46
76
440
4943
omeprazole; oral, parenteral
A02BC01 [21600096]
1.7e+00
1.3e+00
1.9e+00
—
3.4e+00
1.7e+00
1.7e+00
cases:9.33%
controls:1.87%
cases:3.54%
controls:1.04%
cases:1.31%
controls:0.19%
—
—
cases:5.13%
controls:0.19%
cases:5.98%
controls:1.18%
cases:13.58%
controls:2.75%
50
99
486
5190
19
55
517
5234
7
10
529
5279
—
27
10
499
5279
31
62
487
5205
66
138
420
4881
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.4e+00
1.4e+00
1.8e+00
1.0e+50
3.2e+00
2.1e+00
1.7e+00
cases:15.67%
controls:4.50%
cases:10.82%
controls:2.91%
cases:2.99%
controls:0.53%
cases:1.87%
controls:0.00%
cases:12.93%
controls:0.61%
cases:18.73%
controls:2.75%
cases:28.60%
controls:6.58%
84
238
452
5051
58
154
478
5135
16
28
520
5261
10
0
526
5289
68
32
458
5257
97
145
421
5122
139
330
347
4689
lansoprazole; oral
A02BC03 [21600098]
1.6e+00
1.7e+00
1.9e+00
1.0e+50
3.2e+00
1.6e+00
1.4e+00
cases:8.77%
controls:1.82%
cases:4.66%
controls:0.87%
cases:1.31%
controls:0.19%
cases:1.49%
controls:0.00%
cases:4.75%
controls:0.21%
cases:5.79%
controls:1.18%
cases:10.08%
controls:2.75%
47
96
489
5193
25
46
511
5243
7
10
529
5279
8
0
528
5289
25
11
501
5278
30
62
488
5205
49
138
437
4881
Inpatient Visit
IP [9201]
1.3e+00
1.8e+00
1.9e+00
—
3.3e+00
2.0e+00
1.3e+00
cases:28.73%
controls:9.83%
cases:12.69%
controls:2.44%
cases:1.68%
controls:0.26%
—
—
cases:4.94%
controls:0.19%
cases:12.36%
controls:1.96%
cases:15.64%
controls:4.78%
154
520
382
4769
68
129
468
5160
9
14
527
5275
—
26
10
500
5279
64
103
454
5164
76
240
410
4779
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
2.3e+00
3.1e+00
—
—
1.0e+50
3.6e+00
2.4e+00
cases:2.80%
controls:0.28%
cases:2.43%
controls:0.11%
—
—
—
—
cases:1.52%
controls:0.00%
cases:3.47%
controls:0.09%
cases:4.73%
controls:0.44%
15
15
521
5274
13
6
523
5283
—
—
8
0
518
5289
18
5
500
5262
23
22
463
4997
Inpatient Hospital
21 [8717]
1.2e+00
1.6e+00
2.2e+00
—
2.7e+00
1.7e+00
1.8e+00
cases:46.46%
controls:20.25%
cases:28.17%
controls:7.56%
cases:7.84%
controls:0.95%
—
—
cases:11.60%
controls:0.87%
cases:33.59%
controls:8.09%
cases:65.02%
controls:22.79%
249
1071
287
4218
151
400
385
4889
42
50
494
5239
—
61
46
465
5243
174
426
344
4841
316
1144
170
3875
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.6e+00
2.4e+00
—
1.0e+50
3.1e+00
2.4e+00
1.5e+00
cases:5.04%
controls:1.10%
cases:5.04%
controls:0.49%
—
—
cases:3.73%
controls:0.00%
cases:2.09%
controls:0.09%
cases:4.63%
controls:0.44%
cases:7.82%
controls:1.77%
27
58
509
5231
27
26
509
5263
—
20
0
516
5289
11
5
515
5284
24
23
494
5244
38
89
448
4930
alprazolam; oral
N05BA12 [21604577]
1.4e+00
1.9e+00
1.8e+00
—
2.6e+00
1.8e+00
1.5e+00
cases:4.10%
controls:1.06%
cases:3.17%
controls:0.51%
cases:1.31%
controls:0.21%
—
—
cases:1.71%
controls:0.13%
cases:3.09%
controls:0.53%
cases:4.53%
controls:1.10%
22
56
514
5233
17
27
519
5262
7
11
529
5278
—
9
7
517
5282
16
28
502
5239
22
55
464
4964
oxazepam; oral
N05BA04 [21604569]
1.6e+00
1.4e+00
2.0e+00
—
2.2e+00
1.7e+00
2.0e+00
cases:9.33%
controls:2.10%
cases:5.22%
controls:1.30%
cases:1.87%
controls:0.25%
—
—
cases:2.28%
controls:0.25%
cases:6.95%
controls:1.40%
cases:15.43%
controls:2.53%
50
111
486
5178
28
69
508
5220
10
13
526
5276
—
12
13
514
5276
36
74
482
5193
75
127
411
4892
General Surgery
2 [38004447]
1.3e+00
1.7e+00
2.0e+00
—
2.5e+00
1.7e+00
1.6e+00
cases:44.59%
controls:17.79%
cases:26.49%
controls:6.05%
cases:6.34%
controls:0.87%
—
—
cases:8.17%
controls:0.74%
cases:27.41%
controls:6.40%
cases:54.12%
controls:19.76%
239
941
297
4348
142
320
394
4969
34
46
502
5243
—
43
39
483
5250
142
337
376
4930
263
992
223
4027
Pain localized to upper abdomen
R10.1 [45568111]
2.2e+00
3.5e+00
—
1.0e+50
—
2.7e+00
2.3e+00
cases:3.73%
controls:0.42%
cases:3.17%
controls:0.09%
—
—
cases:1.31%
controls:0.00%
—
—
cases:2.70%
controls:0.19%
cases:6.38%
controls:0.68%
20
22
516
5267
17
5
519
5284
—
7
0
529
5289
—
14
10
504
5257
31
34
455
4985
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
2.4e+00
2.9e+00
—
1.0e+50
1.0e+50
2.8e+00
2.6e+00
cases:2.99%
controls:0.28%
cases:2.05%
controls:0.11%
—
—
cases:1.49%
controls:0.00%
cases:1.52%
controls:0.00%
cases:1.93%
controls:0.11%
cases:4.73%
controls:0.38%
16
15
520
5274
11
6
525
5283
—
8
0
528
5289
8
0
518
5289
10
6
508
5261
23
19
463
5000
quetiapine; oral
N05AH04 [21604544]
1.8e+00
1.8e+00
1.6e+00
—
1.8e+00
1.8e+00
1.8e+00
cases:6.16%
controls:1.04%
cases:5.22%
controls:0.87%
cases:1.68%
controls:0.36%
—
—
cases:1.52%
controls:0.26%
cases:4.63%
controls:0.82%
cases:9.05%
controls:1.55%
33
55
503
5234
28
46
508
5243
9
19
527
5270
—
8
14
518
5275
24
43
494
5224
44
78
442
4941
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
3.6e+00
—
—
—
1.0e+50
3.5e+00
3.5e+00
cases:6.90%
controls:0.21%
—
—
—
—
—
—
cases:1.90%
controls:0.00%
cases:4.05%
controls:0.13%
cases:7.61%
controls:0.24%
37
11
499
5278
—
—
—
10
0
516
5289
21
7
497
5260
37
12
449
5007
Depressive episode, unspecified
F32.9 [45571760]
2.3e+00
2.3e+00
1.0e+50
—
—
3.5e+00
2.3e+00
cases:4.48%
controls:0.45%
cases:1.49%
controls:0.15%
cases:0.93%
controls:0.00%
—
—
—
—
cases:3.09%
controls:0.09%
cases:6.58%
controls:0.68%
24
24
512
5265
8
8
528
5281
5
0
531
5289
—
—
16
5
502
5262
32
34
454
4985
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
9.9e-01
1.4e+00
2.7e+00
1.0e+50
2.8e+00
1.5e+00
9.2e-01
cases:9.14%
controls:3.61%
cases:6.90%
controls:1.78%
cases:3.73%
controls:0.26%
cases:1.68%
controls:0.00%
cases:3.61%
controls:0.23%
cases:8.11%
controls:1.96%
cases:13.17%
controls:5.68%
49
191
487
5098
37
94
499
5195
20
14
516
5275
9
0
527
5289
19
12
507
5277
42
103
476
5164
64
285
422
4734
mirtazapine; oral
N06AX11 [21604740]
1.6e+00
1.7e+00
1.9e+00
—
1.7e+00
1.7e+00
1.7e+00
cases:9.51%
controls:2.00%
cases:6.34%
controls:1.25%
cases:1.68%
controls:0.26%
—
—
cases:2.09%
controls:0.40%
cases:6.95%
controls:1.37%
cases:15.23%
controls:3.23%
51
106
485
5183
34
66
502
5223
9
14
527
5275
—
11
21
515
5268
36
72
482
5195
74
162
412
4857
ranitidine; oral, parenteral
A02BA02 [21600083]
1.6e+00
1.6e+00
—
—
3.1e+00
1.9e+00
1.8e+00
cases:7.46%
controls:1.66%
cases:3.36%
controls:0.70%
—
—
—
—
cases:4.37%
controls:0.21%
cases:3.67%
controls:0.57%
cases:9.88%
controls:1.71%
40
88
496
5201
18
37
518
5252
—
—
23
11
503
5278
19
30
499
5237
48
86
438
4933
ranitidine bismuth citrate; oral
A02BA07 [21600088]
1.6e+00
1.6e+00
—
—
3.1e+00
1.9e+00
1.8e+00
cases:7.46%
controls:1.66%
cases:3.36%
controls:0.70%
—
—
—
—
cases:4.37%
controls:0.21%
cases:3.67%
controls:0.57%
cases:9.88%
controls:1.71%
40
88
496
5201
18
37
518
5252
—
—
23
11
503
5278
19
30
499
5237
48
86
438
4933
levomepromazine; oral, parenteral
N05AA02 [21604493]
2.3e+00
2.4e+00
—
—
—
2.5e+00
2.7e+00
cases:2.99%
controls:0.32%
cases:1.87%
controls:0.17%
—
—
—
—
—
—
cases:2.51%
controls:0.21%
cases:6.17%
controls:0.46%
16
17
520
5272
10
9
526
5280
—
—
—
13
11
505
5256
30
23
456
4996
INR in Blood by Coagulation assay
34714-6 [3032080]
1.1e+00
1.5e+00
2.1e+00
—
1.8e+00
2.0e+00
1.4e+00
cases:5.41%
controls:1.91%
cases:5.04%
controls:1.23%
cases:2.61%
controls:0.34%
—
—
cases:2.47%
controls:0.40%
cases:7.34%
controls:1.04%
cases:10.70%
controls:2.95%
29
101
507
5188
27
65
509
5224
14
18
522
5271
—
13
21
513
5268
38
55
480
5212
52
148
434
4871
lactulose; oral
A06AD11 [21600571]
1.6e+00
1.8e+00
2.3e+00
—
—
2.2e+00
1.8e+00
cases:2.99%
controls:0.62%
cases:2.80%
controls:0.49%
cases:1.12%
controls:0.11%
—
—
—
—
cases:3.86%
controls:0.44%
cases:5.97%
controls:1.00%
16
33
520
5256
15
26
521
5263
6
6
530
5283
—
—
20
23
498
5244
29
50
457
4969
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
9.5e-01
1.3e+00
2.2e+00
1.0e+50
2.7e+00
1.5e+00
9.1e-01
cases:9.89%
controls:4.08%
cases:8.40%
controls:2.34%
cases:3.54%
controls:0.40%
cases:5.22%
controls:0.00%
cases:4.75%
controls:0.32%
cases:9.85%
controls:2.45%
cases:14.40%
controls:6.34%
53
216
483
5073
45
124
491
5165
19
21
517
5268
28
0
508
5289
25
17
501
5272
51
129
467
5138
70
318
416
4701
temazepam; oral
N05CD07 [21604642]
1.8e+00
1.8e+00
1.4e+00
—
1.7e+00
2.2e+00
2.1e+00
cases:10.07%
controls:1.78%
cases:6.72%
controls:1.15%
cases:1.31%
controls:0.32%
—
—
cases:2.09%
controls:0.40%
cases:8.88%
controls:1.10%
cases:15.64%
controls:2.15%
54
94
482
5195
36
61
500
5228
7
17
529
5272
—
11
21
515
5268
46
58
472
5209
76
108
410
4911
doxepin; oral, parenteral
N06AA12 [21604699]
1.7e+00
2.8e+00
—
—
—
2.5e+00
2.6e+00
cases:2.61%
controls:0.51%
cases:2.24%
controls:0.13%
—
—
—
—
—
—
cases:2.32%
controls:0.19%
cases:5.56%
controls:0.44%
14
27
522
5262
12
7
524
5282
—
—
—
12
10
506
5257
27
22
459
4997
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
2.2e+00
2.0e+00
—
—
—
3.4e+00
1.9e+00
cases:2.61%
controls:0.28%
cases:1.87%
controls:0.26%
—
—
—
—
—
—
cases:2.90%
controls:0.09%
cases:4.53%
controls:0.70%
14
15
522
5274
10
14
526
5275
—
—
—
15
5
503
5262
22
35
464
4984
Office Visit
OMOP4822458 [581477]
1.1e+00
1.1e+00
—
1.0e+50
3.7e+00
2.0e+00
1.6e+00
cases:10.63%
controls:3.82%
cases:3.17%
controls:1.08%
—
—
cases:2.80%
controls:0.00%
cases:3.80%
controls:0.09%
cases:7.34%
controls:1.04%
cases:19.14%
controls:4.64%
57
202
479
5087
17
57
519
5232
—
15
0
521
5289
20
5
506
5284
38
55
480
5212
93
233
393
4786
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
2.4e+00
2.1e+00
1.0e+50
—
1.0e+50
2.7e+00
2.2e+00
cases:5.97%
controls:0.57%
cases:3.36%
controls:0.43%
cases:1.49%
controls:0.00%
—
—
cases:1.14%
controls:0.00%
cases:3.67%
controls:0.25%
cases:6.79%
controls:0.82%
32
30
504
5259
18
23
518
5266
8
0
528
5289
—
6
0
520
5289
19
13
499
5254
33
41
453
4978
Concussion
S06.0 [45582805]
1.9e+00
2.5e+00
—
—
—
2.7e+00
2.3e+00
cases:2.05%
controls:0.32%
cases:1.31%
controls:0.11%
—
—
—
—
—
—
cases:1.74%
controls:0.11%
cases:5.35%
controls:0.56%
11
17
525
5272
7
6
529
5283
—
—
—
9
6
509
5261
26
28
460
4991
zopiclone; oral
N05CF01 [21604654]
1.7e+00
1.5e+00
9.7e-01
—
2.5e+00
1.6e+00
1.9e+00
cases:16.23%
controls:3.52%
cases:9.89%
controls:2.40%
cases:1.68%
controls:0.64%
—
—
cases:4.94%
controls:0.42%
cases:11.39%
controls:2.49%
cases:25.31%
controls:4.84%
87
186
449
5103
53
127
483
5162
9
34
527
5255
—
26
22
500
5267
59
131
459
5136
123
243
363
4776
Emergency Medicine
93 [38004510]
7.7e-01
1.5e+00
1.9e+00
—
2.7e+00
1.5e+00
7.8e-01
cases:6.34%
controls:3.04%
cases:6.72%
controls:1.63%
cases:1.68%
controls:0.25%
—
—
cases:2.66%
controls:0.19%
cases:6.95%
controls:1.63%
cases:10.08%
controls:4.88%
34
161
502
5128
36
86
500
5203
9
13
527
5276
—
14
10
512
5279
36
86
482
5181
49
245
437
4774
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2.1e+00
2.1e+00
—
—
—
2.8e+00
2.1e+00
cases:3.54%
controls:0.43%
cases:2.43%
controls:0.30%
—
—
—
—
—
—
cases:2.12%
controls:0.13%
cases:5.56%
controls:0.74%
19
23
517
5266
13
16
523
5273
—
—
—
11
7
507
5260
27
37
459
4982
Outpatient Visit
OP [9202]
7.1e-01
5.2e-01
6.6e-01
4.4e+00
1.1e+00
7.7e-01
7.9e-01
cases:53.73%
controls:36.36%
cases:33.02%
controls:22.69%
cases:8.21%
controls:4.41%
cases:11.19%
controls:0.15%
cases:12.55%
controls:4.44%
cases:39.77%
controls:23.41%
cases:67.28%
controls:48.30%
288
1923
248
3366
177
1200
359
4089
44
233
492
5056
60
8
476
5281
66
235
460
5054
206
1233
312
4034
327
2424
159
2595
Monocytes/Leukocytes in Blood
26485-3 [3019069]
8.7e-01
1.1e+00
2.0e+00
—
2.5e+00
1.1e+00
1.1e+00
cases:4.66%
controls:2.00%
cases:3.54%
controls:1.15%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.09%
cases:3.28%
controls:1.10%
cases:9.05%
controls:3.15%
25
106
511
5183
19
61
517
5228
6
8
530
5281
—
6
5
520
5284
17
58
501
5209
44
158
442
4861
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
8.7e-01
1.1e+00
2.0e+00
—
2.5e+00
1.1e+00
1.1e+00
cases:4.66%
controls:2.00%
cases:3.54%
controls:1.15%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.09%
cases:3.28%
controls:1.08%
cases:8.64%
controls:3.17%
25
106
511
5183
19
61
517
5228
6
8
530
5281
—
6
5
520
5284
17
57
501
5210
42
159
444
4860
nizatidine; oral, parenteral
A02BA04 [21600085]
2.0e+00
2.1e+00
—
—
1.0e+50
2.6e+00
2.0e+00
cases:3.36%
controls:0.47%
cases:1.68%
controls:0.21%
—
—
—
—
cases:1.71%
controls:0.00%
cases:2.32%
controls:0.17%
cases:3.29%
controls:0.46%
18
25
518
5264
9
11
527
5278
—
—
9
0
517
5289
12
9
506
5258
16
23
470
4996
Basophils/Leukocytes in Blood
30180-4 [3022096]
8.7e-01
1.1e+00
2.0e+00
—
2.5e+00
1.1e+00
1.1e+00
cases:4.66%
controls:2.00%
cases:3.54%
controls:1.15%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.09%
cases:3.28%
controls:1.08%
cases:8.64%
controls:3.19%
25
106
511
5183
19
61
517
5228
6
8
530
5281
—
6
5
520
5284
17
57
501
5210
42
160
444
4859
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
2.0e+00
2.9e+00
—
—
—
2.0e+00
1.7e+00
cases:2.43%
controls:0.32%
cases:2.43%
controls:0.13%
—
—
—
—
—
—
cases:1.54%
controls:0.21%
cases:4.12%
controls:0.76%
13
17
523
5272
13
7
523
5282
—
—
—
8
11
510
5256
20
38
466
4981
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
7.6e-01
8.9e-01
2.2e+00
—
2.3e+00
1.5e+00
1.0e+00
cases:5.41%
controls:2.61%
cases:3.54%
controls:1.49%
cases:1.31%
controls:0.15%
—
—
cases:1.90%
controls:0.19%
cases:5.60%
controls:1.29%
cases:10.49%
controls:4.02%
29
138
507
5151
19
79
517
5210
7
8
529
5281
—
10
10
516
5279
29
68
489
5199
51
202
435
4817
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
8.7e-01
1.0e+00
2.3e+00
—
2.3e+00
1.1e+00
1.0e+00
cases:4.48%
controls:1.93%
cases:3.36%
controls:1.21%
cases:1.31%
controls:0.13%
—
—
cases:1.14%
controls:0.11%
cases:3.09%
controls:1.10%
cases:8.44%
controls:3.15%
24
102
512
5187
18
64
518
5225
7
7
529
5282
—
6
6
520
5283
16
58
502
5209
41
158
445
4861
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1.2e+00
1.7e+00
2.3e+00
—
—
2.0e+00
1.4e+00
cases:4.85%
controls:1.57%
cases:3.73%
controls:0.70%
cases:1.12%
controls:0.11%
—
—
—
—
cases:4.63%
controls:0.66%
cases:8.23%
controls:2.13%
26
83
510
5206
20
37
516
5252
6
6
530
5283
—
—
24
35
494
5232
40
107
446
4912
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
2.1e+00
2.7e+00
—
—
—
2.2e+00
1.5e+00
cases:2.80%
controls:0.36%
cases:2.24%
controls:0.15%
—
—
—
—
—
—
cases:1.93%
controls:0.21%
cases:4.12%
controls:0.94%
15
19
521
5270
12
8
524
5281
—
—
—
10
11
508
5256
20
47
466
4972
esomeprazole; oral, parenteral
A02BC05 [21600100]
1.4e+00
1.4e+00
1.5e+00
—
2.6e+00
1.8e+00
1.3e+00
cases:9.51%
controls:2.53%
cases:6.34%
controls:1.63%
cases:1.12%
controls:0.26%
—
—
cases:3.80%
controls:0.28%
cases:7.53%
controls:1.33%
cases:13.17%
controls:3.98%
51
134
485
5155
34
86
502
5203
6
14
530
5275
—
20
15
506
5274
39
70
479
5197
64
200
422
4819
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
2.0e+00
2.8e+00
—
—
—
2.0e+00
1.7e+00
cases:2.24%
controls:0.32%
cases:2.24%
controls:0.13%
—
—
—
—
—
—
cases:1.54%
controls:0.21%
cases:4.12%
controls:0.82%
12
17
524
5272
12
7
524
5282
—
—
—
8
11
510
5256
20
41
466
4978
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
9.2e-01
1.1e+00
2.0e+00
—
2.3e+00
1.1e+00
1.1e+00
cases:5.04%
controls:2.06%
cases:3.54%
controls:1.23%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.11%
cases:3.09%
controls:1.10%
cases:9.05%
controls:3.29%
27
109
509
5180
19
65
517
5224
6
8
530
5281
—
6
6
520
5283
16
58
502
5209
44
165
442
4854
ECG with 12 standard connections
XF400 [2001303368]
2.0e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.8e+00
cases:6.16%
controls:0.91%
cases:2.61%
controls:0.28%
—
—
cases:2.05%
controls:0.00%
—
—
cases:2.90%
controls:0.27%
cases:6.58%
controls:1.18%
33
48
503
5241
14
15
522
5274
—
11
0
525
5289
—
15
14
503
5253
32
59
454
4960
Outpatient Hospital
22 [8756]
8.4e-01
1.0e+00
1.7e+00
1.0e+50
2.1e+00
1.4e+00
1.3e+00
cases:27.05%
controls:13.80%
cases:12.13%
controls:4.76%
cases:2.61%
controls:0.51%
cases:5.78%
controls:0.00%
cases:3.80%
controls:0.47%
cases:16.22%
controls:4.61%
cases:41.77%
controls:16.04%
145
730
391
4559
65
252
471
5037
14
27
522
5262
31
0
505
5289
20
25
506
5264
84
243
434
5024
203
805
283
4214
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3039X [2000402887]
4.0e+00
—
—
1.0e+50
1.0e+50
—
4.2e+00
cases:9.33%
controls:0.19%
—
—
—
—
cases:2.05%
controls:0.00%
cases:1.71%
controls:0.00%
—
—
cases:6.17%
controls:0.10%
50
10
486
5279
—
—
11
0
525
5289
9
0
517
5289
—
30
5
456
5014
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.1e+00
1.6e+00
1.9e+00
—
2.5e+00
1.7e+00
1.2e+00
cases:4.85%
controls:1.68%
cases:3.73%
controls:0.81%
cases:1.12%
controls:0.17%
—
—
cases:1.14%
controls:0.09%
cases:4.44%
controls:0.84%
cases:8.64%
controls:2.71%
26
89
510
5200
20
43
516
5246
6
9
530
5280
—
6
5
520
5284
23
44
495
5223
42
136
444
4883
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
8.2e-01
9.8e-01
2.0e+00
—
2.2e+00
9.8e-01
9.2e-01
cases:4.85%
controls:2.19%
cases:3.36%
controls:1.29%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.13%
cases:3.09%
controls:1.18%
cases:8.64%
controls:3.65%
26
116
510
5173
18
68
518
5221
6
8
530
5281
—
6
7
520
5282
16
62
502
5205
42
183
444
4836
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
1.1e+00
1.8e+00
2.5e+00
—
—
1.6e+00
7.4e-01
cases:4.66%
controls:1.55%
cases:3.73%
controls:0.64%
cases:1.12%
controls:0.09%
—
—
—
—
cases:3.67%
controls:0.74%
cases:5.76%
controls:2.83%
25
82
511
5207
20
34
516
5255
6
5
530
5284
—
—
19
39
499
5228
28
142
458
4877
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.1e+00
1.4e+00
1.7e+00
—
2.1e+00
1.6e+00
1.6e+00
cases:9.51%
controls:3.54%
cases:5.41%
controls:1.46%
cases:1.12%
controls:0.21%
—
—
cases:2.47%
controls:0.32%
cases:6.18%
controls:1.25%
cases:20.16%
controls:5.06%
51
187
485
5102
29
77
507
5212
6
11
530
5278
—
13
17
513
5272
32
66
486
5201
98
254
388
4765
Addiction caused by alcohol UNS
F10.29 [2000501684]
3.5e+00
—
—
—
1.0e+50
—
4.1e+00
cases:6.53%
controls:0.21%
—
—
—
—
—
—
cases:1.33%
controls:0.00%
—
—
cases:12.14%
controls:0.22%
35
11
501
5278
—
—
—
7
0
519
5289
—
59
11
427
5008
Emergency Room and Inpatient Visit
ERIP [262]
1.2e+00
2.7e+00
—
1.0e+50
—
2.5e+00
1.2e+00
cases:2.43%
controls:0.76%
cases:4.29%
controls:0.30%
—
—
cases:2.24%
controls:0.00%
—
—
cases:4.83%
controls:0.42%
cases:6.38%
controls:1.97%
13
40
523
5249
23
16
513
5273
—
12
0
524
5289
—
25
22
493
5245
31
99
455
4920
Cathetrisation of vein
TPH04 [2001309597]
1.7e+00
1.9e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:4.10%
controls:0.79%
cases:1.87%
controls:0.28%
—
—
cases:1.31%
controls:0.00%
—
—
cases:1.93%
controls:0.17%
cases:4.32%
controls:1.04%
22
42
514
5247
10
15
526
5274
—
7
0
529
5289
—
10
9
508
5258
21
52
465
4967
Eosinophils [#/volume] in Blood
26449-9 [3013115]
7.4e-01
1.1e+00
2.0e+00
—
2.5e+00
1.0e+00
9.3e-01
cases:4.48%
controls:2.19%
cases:3.54%
controls:1.25%
cases:1.12%
controls:0.15%
—
—
cases:1.33%
controls:0.11%
cases:3.28%
controls:1.23%
cases:8.85%
controls:3.71%
24
116
512
5173
19
66
517
5223
6
8
530
5281
—
7
6
519
5283
17
65
501
5202
43
186
443
4833
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
1.6e+00
1.8e+00
—
1.0e+50
—
2.5e+00
1.6e+00
cases:4.66%
controls:1.00%
cases:2.99%
controls:0.51%
—
—
cases:1.87%
controls:0.00%
—
—
cases:4.83%
controls:0.42%
cases:6.79%
controls:1.47%
25
53
511
5236
16
27
520
5262
—
10
0
526
5289
—
25
22
493
5245
33
74
453
4945
Normoblasts [#/volume] in Blood
715-3 [3021589]
8.7e-01
1.0e+00
2.3e+00
—
2.4e+00
8.5e-01
7.9e-01
cases:4.10%
controls:1.76%
cases:4.29%
controls:1.59%
cases:2.43%
controls:0.25%
—
—
cases:1.71%
controls:0.15%
cases:3.28%
controls:1.42%
cases:7.00%
controls:3.31%
22
93
514
5196
23
84
513
5205
13
13
523
5276
—
9
8
517
5281
17
75
501
5192
34
166
452
4853
Anaemia, unspecified
D64.9 [45600610]
2.6e+00
—
—
—
—
2.8e+00
2.0e+00
cases:1.68%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.11%
cases:2.67%
controls:0.38%
9
7
527
5282
—
—
—
—
10
6
508
5261
13
19
473
5000
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
2.1e+00
2.8e+00
—
—
—
2.5e+00
—
cases:1.68%
controls:0.21%
cases:2.05%
controls:0.13%
—
—
—
—
—
—
cases:1.16%
controls:0.09%
—
—
9
11
527
5278
11
7
525
5282
—
—
—
6
5
512
5262
—
clonazepam; oral, parenteral
N03AE01 [21604415]
2.0e+00
1.8e+00
—
—
2.3e+00
1.8e+00
1.8e+00
cases:2.61%
controls:0.36%
cases:2.05%
controls:0.34%
—
—
—
—
cases:0.95%
controls:0.09%
cases:1.74%
controls:0.30%
cases:3.09%
controls:0.54%
14
19
522
5270
11
18
525
5271
—
—
5
5
521
5284
9
16
509
5251
15
27
471
4992
Monocytes [#/volume] in Blood
26484-6 [3001604]
7.3e-01
1.0e+00
2.0e+00
—
2.3e+00
1.0e+00
9.7e-01
cases:4.29%
controls:2.12%
cases:3.36%
controls:1.23%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.11%
cases:3.09%
controls:1.16%
cases:8.64%
controls:3.47%
23
112
513
5177
18
65
518
5224
6
8
530
5281
—
6
6
520
5283
16
61
502
5206
42
174
444
4845
Basophils [#/volume] in Blood
26444-0 [3006315]
7.3e-01
1.0e+00
2.0e+00
—
2.3e+00
1.0e+00
9.4e-01
cases:4.29%
controls:2.12%
cases:3.36%
controls:1.25%
cases:1.12%
controls:0.15%
—
—
cases:1.14%
controls:0.11%
cases:3.09%
controls:1.16%
cases:8.64%
controls:3.55%
23
112
513
5177
18
66
518
5223
6
8
530
5281
—
6
6
520
5283
16
61
502
5206
42
178
444
4841
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2.2e+00
2.7e+00
—
—
—
2.3e+00
1.0e+00
cases:1.68%
controls:0.19%
cases:1.68%
controls:0.11%
—
—
—
—
—
—
cases:1.35%
controls:0.13%
cases:1.03%
controls:0.38%
9
10
527
5279
9
6
527
5283
—
—
—
7
7
511
5260
5
19
481
5000
Exposure to unspecified factor
X59 [45756412]
1.6e+00
1.7e+00
—
—
—
2.1e+00
1.7e+00
cases:3.73%
controls:0.78%
cases:1.49%
controls:0.26%
—
—
—
—
—
—
cases:1.74%
controls:0.21%
cases:4.94%
controls:0.90%
20
41
516
5248
8
14
528
5275
—
—
—
9
11
509
5256
24
45
462
4974
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
6.6e-01
1.3e+00
1.7e+00
1.0e+50
2.1e+00
1.1e+00
1.0e+00
cases:4.66%
controls:2.48%
cases:4.85%
controls:1.40%
cases:1.49%
controls:0.28%
cases:1.31%
controls:0.00%
cases:1.71%
controls:0.21%
cases:4.44%
controls:1.50%
cases:10.08%
controls:3.96%
25
131
511
5158
26
74
510
5215
8
15
528
5274
7
0
529
5289
9
11
517
5278
23
79
495
5188
49
199
437
4820
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.7e+00
1.4e+00
—
—
—
2.0e+00
2.1e+00
cases:5.97%
controls:1.12%
cases:2.05%
controls:0.53%
—
—
—
—
—
—
cases:4.05%
controls:0.55%
cases:12.76%
controls:1.83%
32
59
504
5230
11
28
525
5261
—
—
—
21
29
497
5238
62
92
424
4927
Bloodpressure measurement
XF600 [2001303376]
2.4e+00
—
—
—
—
2.3e+00
2.3e+00
cases:1.49%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.44%
controls:0.14%
8
7
528
5282
—
—
—
—
5
5
513
5262
7
7
479
5012
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
3.3e+00
—
—
—
—
—
3.7e+00
cases:2.61%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:6.17%
controls:0.16%
14
5
522
5284
—
—
—
—
—
30
8
456
5011
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
1.7e+00
1.7e+00
—
—
—
2.1e+00
1.4e+00
cases:3.54%
controls:0.66%
cases:1.68%
controls:0.30%
—
—
—
—
—
—
cases:2.12%
controls:0.27%
cases:4.73%
controls:1.24%
19
35
517
5254
9
16
527
5273
—
—
—
11
14
507
5253
23
62
463
4957
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.1e+00
1.9e+00
—
—
—
2.0e+00
1.9e+00
cases:2.43%
controls:0.83%
cases:2.05%
controls:0.32%
—
—
—
—
—
—
cases:2.90%
controls:0.42%
cases:5.56%
controls:0.86%
13
44
523
5245
11
17
525
5272
—
—
—
15
22
503
5245
27
43
459
4976
Poisoning by systemic antibiotics
T36 [45756588]
3.0e+00
—
—
—
—
—
3.9e+00
cases:3.17%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:7.82%
controls:0.18%
17
9
519
5280
—
—
—
—
—
38
9
448
5010
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.6e+00
1.6e+00
—
—
—
2.2e+00
1.4e+00
cases:7.28%
controls:1.57%
cases:4.48%
controls:0.95%
—
—
—
—
—
—
cases:5.41%
controls:0.63%
cases:9.26%
controls:2.53%
39
83
497
5206
24
50
512
5239
—
—
—
28
33
490
5234
45
127
441
4892
Bacteria identified in Blood by Culture
600-7 [3023368]
1.4e+00
1.8e+00
—
—
—
2.3e+00
1.2e+00
cases:3.54%
controls:0.89%
cases:2.61%
controls:0.45%
—
—
—
—
—
—
cases:3.09%
controls:0.32%
cases:5.35%
controls:1.63%
19
47
517
5242
14
24
522
5265
—
—
—
16
17
502
5250
26
82
460
4937
Laboratory Visit
OMOP4822461 [32036]
1.6e-01
2.8e-01
1.2e+00
4.3e+00
1.2e+00
2.6e-01
4.6e-02
cases:11.57%
controls:10.00%
cases:12.13%
controls:9.45%
cases:7.65%
controls:2.38%
cases:8.58%
controls:0.13%
cases:7.41%
controls:2.34%
cases:12.55%
controls:10.01%
cases:17.28%
controls:16.64%
62
529
474
4760
65
500
471
4789
41
126
495
5163
46
7
490
5282
39
124
487
5165
65
527
453
4740
84
835
402
4184
famotidine; oral, parenteral
A02BA03 [21600084]
2.0e+00
—
—
—
1.0e+50
2.7e+00
1.9e+00
cases:1.68%
controls:0.23%
—
—
—
—
—
—
cases:1.33%
controls:0.00%
cases:1.74%
controls:0.11%
cases:2.26%
controls:0.34%
9
12
527
5277
—
—
—
7
0
519
5289
9
6
509
5261
11
17
475
5002
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.2e-01
9.6e-01
1.9e+00
—
2.2e+00
1.1e+00
4.6e-01
cases:9.89%
controls:6.13%
cases:8.96%
controls:3.63%
cases:4.10%
controls:0.62%
—
—
cases:4.75%
controls:0.57%
cases:10.23%
controls:3.68%
cases:15.02%
controls:10.08%
53
324
483
4965
48
192
488
5097
22
33
514
5256
—
25
30
501
5259
53
194
465
5073
73
506
413
4513
Supine thorax X-ray examination
GD1QA [2001303648]
1.7e+00
2.0e+00
—
—
—
3.0e+00
1.9e+00
cases:1.87%
controls:0.36%
cases:0.93%
controls:0.13%
—
—
—
—
—
—
cases:1.93%
controls:0.09%
cases:4.12%
controls:0.66%
10
19
526
5270
5
7
531
5282
—
—
—
10
5
508
5262
20
33
466
4986
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
2.4e+00
2.1e+00
—
—
—
2.0e+00
6.5e-01
cases:2.43%
controls:0.23%
cases:1.49%
controls:0.19%
—
—
—
—
—
—
cases:1.74%
controls:0.25%
cases:3.09%
controls:1.63%
13
12
523
5277
8
10
528
5279
—
—
—
9
13
509
5254
15
82
471
4937
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
5.4e-01
9.4e-01
—
—
3.1e+00
1.4e+00
1.0e+00
cases:5.04%
controls:2.99%
cases:3.36%
controls:1.34%
—
—
—
—
cases:2.09%
controls:0.09%
cases:4.44%
controls:1.18%
cases:10.08%
controls:3.91%
27
158
509
5131
18
71
518
5218
—
—
11
5
515
5284
23
62
495
5205
49
196
437
4823
pH of Serum or Plasma
2753-2 [3018418]
1.4e+00
1.8e+00
—
—
—
1.8e+00
1.4e+00
cases:3.73%
controls:0.96%
cases:2.99%
controls:0.51%
—
—
—
—
—
—
cases:3.28%
controls:0.53%
cases:5.76%
controls:1.47%
20
51
516
5238
16
27
520
5262
—
—
—
17
28
501
5239
28
74
458
4945
Anxiety disorder, unspecified
F41.9 [45542849]
—
2.1e+00
—
—
—
2.2e+00
2.0e+00
—
—
cases:1.12%
controls:0.13%
—
—
—
—
—
—
cases:1.54%
controls:0.17%
cases:2.06%
controls:0.28%
—
6
7
530
5282
—
—
—
8
9
510
5258
10
14
476
5005
Other symptoms involving abdomen and pelvis, Abdominal pain
7890A [2000407034]
2.7e+00
—
—
—
—
—
3.7e+00
cases:3.73%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:4.53%
controls:0.12%
20
14
516
5275
—
—
—
—
—
22
6
464
5013
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
1.7e+00
2.3e+00
—
—
—
2.3e+00
7.3e-01
cases:2.05%
controls:0.38%
cases:1.87%
controls:0.19%
—
—
—
—
—
—
cases:1.54%
controls:0.15%
cases:1.85%
controls:0.90%
11
20
525
5269
10
10
526
5279
—
—
—
8
8
510
5259
9
45
477
4974
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
F10.2 [45576496]
2.7e+00
—
—
—
—
—
3.7e+00
cases:1.87%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:4.53%
controls:0.12%
10
7
526
5282
—
—
—
—
—
22
6
464
5013
Differential panel, method unspecified - Blood
69738-3 [42870588]
1.2e+00
7.1e-01
—
—
2.5e+00
1.3e+00
1.2e+00
cases:4.66%
controls:1.46%
cases:1.87%
controls:0.93%
—
—
—
—
cases:1.14%
controls:0.09%
cases:2.70%
controls:0.72%
cases:5.97%
controls:1.85%
25
77
511
5212
10
49
526
5240
—
—
6
5
520
5284
14
38
504
5229
29
93
457
4926
dixyrazine; oral, parenteral
N05AB01 [21604500]
2.5e+00
—
—
—
—
—
3.6e+00
cases:1.87%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:4.32%
controls:0.12%
10
8
526
5281
—
—
—
—
—
21
6
465
5013
Thorax X-ray examination
GD1AA [2001303617]
1.4e+00
1.6e+00
—
1.0e+50
—
1.9e+00
1.2e+00
cases:6.72%
controls:1.82%
cases:3.54%
controls:0.74%
—
—
cases:1.49%
controls:0.00%
—
—
cases:4.44%
controls:0.68%
cases:9.26%
controls:2.89%
36
96
500
5193
19
39
517
5250
—
8
0
528
5289
—
23
36
495
5231
45
145
441
4874
carbamazepine; oral, rectal
N03AF01 [21604417]
1.3e+00
1.3e+00
—
—
1.7e+00
1.6e+00
1.8e+00
cases:3.17%
controls:0.85%
cases:2.43%
controls:0.68%
—
—
—
—
cases:1.14%
controls:0.21%
cases:2.90%
controls:0.59%
cases:4.73%
controls:0.78%
17
45
519
5244
13
36
523
5253
—
—
6
11
520
5278
15
31
503
5236
23
39
463
4980
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
2.3e+00
2.3e+00
—
—
—
—
1.4e+00
cases:2.05%
controls:0.21%
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.56%
11
11
525
5278
6
6
530
5283
—
—
—
—
11
28
475
4991
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.4e+00
1.8e+00
—
—
1.0e+50
1.5e+00
1.2e+00
cases:2.61%
controls:0.64%
cases:2.80%
controls:0.47%
—
—
—
—
cases:0.95%
controls:0.00%
cases:2.70%
controls:0.59%
cases:4.73%
controls:1.43%
14
34
522
5255
15
25
521
5264
—
—
5
0
521
5289
14
31
504
5236
23
72
463
4947
citalopram; oral, parenteral
N06AB04 [21604712]
1.4e+00
1.3e+00
1.4e+00
—
1.6e+00
1.6e+00
1.6e+00
cases:8.21%
controls:2.10%
cases:3.92%
controls:1.06%
cases:1.12%
controls:0.28%
—
—
cases:1.33%
controls:0.28%
cases:5.60%
controls:1.22%
cases:11.73%
controls:2.57%
44
111
492
5178
21
56
515
5233
6
15
530
5274
—
7
15
519
5274
29
64
489
5203
57
129
429
4890
Bacteria [Presence] in Urine
87829-8 [36304419]
1.2e+00
2.0e+00
—
—
—
1.6e+00
1.1e+00
cases:2.99%
controls:0.95%
cases:2.61%
controls:0.36%
—
—
—
—
—
—
cases:2.32%
controls:0.46%
cases:4.73%
controls:1.63%
16
50
520
5239
14
19
522
5270
—
—
—
12
24
506
5243
23
82
463
4937
Malaise and fatigue
R53 [45553741]
2.1e+00
1.6e+00
—
—
—
2.3e+00
1.4e+00
cases:2.99%
controls:0.36%
cases:1.12%
controls:0.23%
—
—
—
—
—
—
cases:1.54%
controls:0.15%
cases:4.12%
controls:1.04%
16
19
520
5270
6
12
530
5277
—
—
—
8
8
510
5259
20
52
466
4967
Physiotherapy
R4110 [2001310233]
1.0e+00
1.9e+00
—
—
—
1.7e+00
1.2e+00
cases:3.54%
controls:1.29%
cases:2.05%
controls:0.30%
—
—
—
—
—
—
cases:2.32%
controls:0.42%
cases:4.94%
controls:1.57%
19
68
517
5221
11
16
525
5273
—
—
—
12
22
506
5245
24
79
462
4940
Monitored bed care
WX892 [2001310850]
2.8e+00
—
—
—
—
1.0e+50
3.0e+00
cases:2.43%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.00%
cases:2.67%
controls:0.14%
13
8
523
5281
—
—
—
—
6
0
512
5267
13
7
473
5012
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
1.1e+00
2.0e+00
—
—
—
1.6e+00
1.0e+00
cases:2.80%
controls:0.91%
cases:2.43%
controls:0.34%
—
—
—
—
—
—
cases:2.32%
controls:0.49%
cases:4.73%
controls:1.71%
15
48
521
5241
13
18
523
5271
—
—
—
12
26
506
5241
23
86
463
4933
loperamide oxide; oral
A07DA05 [21600648]
1.8e+00
—
—
—
—
2.0e+00
1.9e+00
cases:2.61%
controls:0.43%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.19%
cases:2.06%
controls:0.30%
14
23
522
5266
—
—
—
—
7
10
511
5257
10
15
476
5004
loperamide; oral
A07DA03 [21600646]
1.8e+00
—
—
—
—
2.0e+00
1.9e+00
cases:2.61%
controls:0.43%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.19%
cases:2.06%
controls:0.30%
14
23
522
5266
—
—
—
—
7
10
511
5257
10
15
476
5004
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2.8e+00
2.9e+00
—
—
—
—
1.5e+00
cases:1.49%
controls:0.09%
cases:1.68%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.24%
8
5
528
5284
9
5
527
5284
—
—
—
—
5
12
481
5007
Pharmacy visit
OMOP4822462 [581458]
2.7e-01
5.5e-01
5.8e-01
1.7e+00
1.2e+00
5.8e-01
9.2e-01
cases:72.01%
controls:66.33%
cases:68.47%
controls:55.72%
cases:35.07%
controls:23.20%
cases:6.16%
controls:1.15%
cases:52.28%
controls:23.96%
cases:72.20%
controls:59.22%
cases:93.00%
controls:84.08%
386
3508
150
1781
367
2947
169
2342
188
1227
348
4062
33
61
503
5228
275
1267
251
4022
374
3119
144
2148
452
4220
34
799
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
1.6e+00
1.6e+00
—
—
—
1.3e+00
9.8e-01
cases:5.41%
controls:1.10%
cases:2.43%
controls:0.49%
—
—
—
—
—
—
cases:2.51%
controls:0.66%
cases:7.41%
controls:2.93%
29
58
507
5231
13
26
523
5263
—
—
—
13
35
505
5232
36
147
450
4872
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.6e-01
7.0e-01
1.8e+00
1.0e+50
2.2e+00
7.4e-01
2.9e-01
cases:7.46%
controls:5.35%
cases:8.21%
controls:4.24%
cases:5.04%
controls:0.85%
cases:4.48%
controls:0.00%
cases:5.70%
controls:0.64%
cases:9.27%
controls:4.63%
cases:12.14%
controls:9.34%
40
283
496
5006
44
224
492
5065
27
45
509
5244
24
0
512
5289
30
34
496
5255
48
244
470
5023
59
469
427
4550
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
1.7e+00
2.0e+00
—
—
—
—
1.8e+00
cases:2.05%
controls:0.40%
cases:1.68%
controls:0.23%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.38%
11
21
525
5268
9
12
527
5277
—
—
—
—
11
19
475
5000
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
1.1e+00
1.9e+00
—
—
—
1.5e+00
9.8e-01
cases:2.99%
controls:0.98%
cases:2.61%
controls:0.42%
—
—
—
—
—
—
cases:2.51%
controls:0.59%
cases:5.14%
controls:1.99%
16
52
520
5237
14
22
522
5267
—
—
—
13
31
505
5236
25
100
461
4919
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
9.3e-01
1.3e+00
—
1.0e+50
—
2.2e+00
1.0e+00
cases:3.73%
controls:1.51%
cases:3.17%
controls:0.85%
—
—
cases:3.36%
controls:0.00%
—
—
cases:3.67%
controls:0.44%
cases:5.76%
controls:2.17%
20
80
516
5209
17
45
519
5244
—
18
0
518
5289
—
19
23
499
5244
28
109
458
4910
Mixed anxiety and depressive disorder
F41.2 [45566845]
2.6e+00
—
—
—
—
—
2.8e+00
cases:2.05%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:3.09%
controls:0.20%
11
8
525
5281
—
—
—
—
—
15
10
471
5009
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
4.4e-01
6.8e-01
1.9e+00
—
2.2e+00
6.1e-01
2.1e-01
cases:8.21%
controls:5.43%
cases:8.02%
controls:4.22%
cases:5.41%
controls:0.89%
—
—
cases:5.32%
controls:0.62%
cases:8.30%
controls:4.71%
cases:11.93%
controls:9.92%
44
287
492
5002
43
223
493
5066
29
47
507
5242
—
28
33
498
5256
43
248
475
5019
58
498
428
4521
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
4.0e-01
5.4e-01
1.8e+00
—
2.2e+00
7.8e-01
2.5e-01
cases:10.26%
controls:7.09%
cases:9.33%
controls:5.65%
cases:5.60%
controls:0.98%
—
—
cases:6.08%
controls:0.74%
cases:11.78%
controls:5.77%
cases:15.64%
controls:12.57%
55
375
481
4914
50
299
486
4990
30
52
506
5237
—
32
39
494
5250
61
304
457
4963
76
631
410
4388
Other and unspecified convulsions
R56.8 [45602033]
2.4e+00
—
—
—
—
—
2.9e+00
cases:3.36%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:4.94%
controls:0.30%
18
17
518
5272
—
—
—
—
—
24
15
462
5004
Bacteria identified in Isolate by Culture
43409-2 [3042936]
1.9e+00
—
—
—
—
2.1e+00
1.2e+00
cases:2.43%
controls:0.38%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.17%
cases:3.29%
controls:0.98%
13
20
523
5269
—
—
—
—
7
9
511
5258
16
49
470
4970
Case Management Agency
251B00000X [38004193]
2.8e-01
2.4e-01
8.1e-01
3.2e+00
8.3e-01
3.2e-01
3.8e-01
cases:29.48%
controls:24.09%
cases:20.71%
controls:17.02%
cases:11.57%
controls:5.52%
cases:8.21%
controls:0.38%
cases:11.60%
controls:5.39%
cases:23.55%
controls:18.30%
cases:41.56%
controls:32.76%
158
1274
378
4015
111
900
425
4389
62
292
474
4997
44
20
492
5269
61
285
465
5004
122
964
396
4303
202
1644
284
3375
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.2e-01
1.6e+00
—
—
—
2.0e+00
1.6e+00
cases:2.61%
controls:1.42%
cases:2.05%
controls:0.43%
—
—
—
—
—
—
cases:2.51%
controls:0.36%
cases:7.00%
controls:1.47%
14
75
522
5214
11
23
525
5266
—
—
—
13
19
505
5248
34
74
452
4945
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
1.5e+00
1.6e+00
—
—
—
2.0e+00
1.6e+00
cases:1.87%
controls:0.43%
cases:1.31%
controls:0.26%
—
—
—
—
—
—
cases:1.16%
controls:0.15%
cases:1.85%
controls:0.40%
10
23
526
5266
7
14
529
5275
—
—
—
6
8
512
5259
9
20
477
4999
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
1.3e+00
1.2e+00
—
—
—
2.0e+00
1.6e+00
cases:3.73%
controls:1.00%
cases:2.05%
controls:0.61%
—
—
—
—
—
—
cases:3.67%
controls:0.49%
cases:5.97%
controls:1.24%
20
53
516
5236
11
32
525
5257
—
—
—
19
26
499
5241
29
62
457
4957
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
2.4e+00
1.0e+50
—
—
—
—
2.5e+00
cases:2.05%
controls:0.19%
cases:0.93%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.22%
11
10
525
5279
5
0
531
5289
—
—
—
—
13
11
473
5008
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
1.5e+00
2.1e+00
—
—
—
2.8e+00
6.8e-01
cases:0.93%
controls:0.21%
cases:1.68%
controls:0.21%
—
—
—
—
—
—
cases:1.54%
controls:0.09%
cases:1.65%
controls:0.84%
5
11
531
5278
9
11
527
5278
—
—
—
8
5
510
5262
8
42
478
4977
Open wound of scalp
S01.0 [45592468]
2.4e+00
—
—
—
—
—
2.5e+00
cases:2.61%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:4.73%
controls:0.40%
14
13
522
5276
—
—
—
—
—
23
20
463
4999
Chest pain, unspecified
R07.4 [45558450]
1.4e+00
1.3e+00
—
1.0e+50
—
1.7e+00
1.6e+00
cases:4.66%
controls:1.19%
cases:1.87%
controls:0.49%
—
—
cases:1.12%
controls:0.00%
—
—
cases:2.51%
controls:0.46%
cases:8.85%
controls:1.83%
25
63
511
5226
10
26
526
5263
—
6
0
530
5289
—
13
24
505
5243
43
92
443
4927
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
4.1e-01
5.4e-01
1.8e+00
—
2.2e+00
8.0e-01
2.7e-01
cases:10.07%
controls:6.92%
cases:9.14%
controls:5.56%
cases:5.60%
controls:0.96%
—
—
cases:6.08%
controls:0.74%
cases:11.58%
controls:5.56%
cases:15.64%
controls:12.39%
54
366
482
4923
49
294
487
4995
30
51
506
5238
—
32
39
494
5250
60
293
458
4974
76
622
410
4397
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
3.9e-01
5.9e-01
1.7e+00
—
1.8e+00
5.8e-01
2.4e-01
cases:11.19%
controls:7.88%
cases:10.07%
controls:5.84%
cases:5.04%
controls:0.95%
—
—
cases:5.13%
controls:0.85%
cases:11.20%
controls:6.57%
cases:16.46%
controls:13.43%
60
417
476
4872
54
309
482
4980
27
50
509
5239
—
27
45
499
5244
58
346
460
4921
80
674
406
4345
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.0e+00
1.7e+00
—
—
—
1.2e+00
8.6e-01
cases:2.99%
controls:1.12%
cases:2.61%
controls:0.51%
—
—
—
—
—
—
cases:2.51%
controls:0.78%
cases:5.56%
controls:2.43%
16
59
520
5230
14
27
522
5262
—
—
—
13
41
505
5226
27
122
459
4897
Abdominal ultrasound examination
JN3AE [2001305555]
2.2e+00
—
—
—
—
—
2.5e+00
cases:2.43%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:4.12%
controls:0.34%
13
15
523
5274
—
—
—
—
—
20
17
466
5002
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
9.8e-01
1.7e+00
—
—
—
1.7e+00
1.3e+00
cases:2.24%
controls:0.85%
cases:1.68%
controls:0.30%
—
—
—
—
—
—
cases:1.54%
controls:0.28%
cases:4.12%
controls:1.20%
12
45
524
5244
9
16
527
5273
—
—
—
8
15
510
5252
20
60
466
4959
Oral Surgery
19 [38004464]
—
2.1e+00
—
—
—
2.5e+00
2.1e+00
—
—
cases:0.93%
controls:0.11%
—
—
—
—
—
—
cases:1.16%
controls:0.09%
cases:2.47%
controls:0.30%
—
5
6
531
5283
—
—
—
6
5
512
5262
12
15
474
5004
Stomach Pathology biopsy report
66114-0 [40768797]
2.5e+00
—
—
1.0e+50
—
—
2.1e+00
cases:3.17%
controls:0.26%
—
—
—
—
cases:2.43%
controls:0.00%
—
—
—
—
cases:3.09%
controls:0.40%
17
14
519
5275
—
—
13
0
523
5289
—
—
15
20
471
4999
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
2.6e+00
—
—
—
—
—
1.9e+00
cases:1.31%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.32%
7
5
529
5284
—
—
—
—
—
10
16
476
5003
Nausea and vomiting
R11 [45539317]
2.1e+00
—
—
—
—
2.5e+00
2.0e+00
cases:0.93%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.09%
cases:2.26%
controls:0.32%
5
6
531
5283
—
—
—
—
6
5
512
5262
11
16
475
5003
Unspecified nonorganic psychosis
F29 [45533099]
2.1e+00
—
—
—
—
—
2.3e+00
cases:1.12%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.12%
6
7
530
5282
—
—
—
—
—
6
6
480
5013
zolpidem; oral
N05CF02 [21604655]
1.4e+00
1.2e+00
—
—
1.6e+00
1.6e+00
1.6e+00
cases:3.73%
controls:0.98%
cases:1.68%
controls:0.53%
—
—
—
—
cases:0.95%
controls:0.19%
cases:2.90%
controls:0.63%
cases:6.17%
controls:1.35%
20
52
516
5237
9
28
527
5261
—
—
5
10
521
5279
15
33
503
5234
30
68
456
4951
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
—
1.9e+00
—
—
—
2.5e+00
7.3e-01
—
—
cases:1.49%
controls:0.23%
—
—
—
—
—
—
cases:1.16%
controls:0.09%
cases:1.23%
controls:0.60%
—
8
12
528
5277
—
—
—
6
5
512
5262
6
30
480
4989
CBC panel - Blood by Automated count
58410-2 [40761511]
3.5e-01
5.9e-01
1.5e+00
—
1.5e+00
7.3e-01
2.1e-01
cases:10.07%
controls:7.30%
cases:8.21%
controls:4.73%
cases:3.92%
controls:0.87%
—
—
cases:4.18%
controls:0.95%
cases:9.65%
controls:4.90%
cases:14.40%
controls:11.99%
54
386
482
4903
44
250
492
5039
21
46
515
5243
—
22
50
504
5239
50
258
468
5009
70
602
416
4417
escitalopram; oral
N06AB10 [21604718]
1.7e+00
1.5e+00
—
—
—
6.9e-01
1.2e+00
cases:3.92%
controls:0.74%
cases:2.24%
controls:0.53%
—
—
—
—
—
—
cases:1.54%
controls:0.78%
cases:5.14%
controls:1.65%
21
39
515
5250
12
28
524
5261
—
—
—
8
41
510
5226
25
83
461
4936
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
2.3e+00
—
—
—
—
—
2.0e+00
cases:1.68%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.34%
9
9
527
5280
—
—
—
—
—
12
17
474
5002
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
1.2e+00
2.3e+00
—
—
—
2.0e+00
2.3e+00
cases:1.12%
controls:0.34%
cases:0.93%
controls:0.09%
—
—
—
—
—
—
cases:1.35%
controls:0.19%
cases:3.91%
controls:0.40%
6
18
530
5271
5
5
531
5284
—
—
—
7
10
511
5257
19
20
467
4999
Alcohol dependence currently independent
F10.20 [2000501677]
—
—
—
—
—
—
4.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.02%
controls:0.12%
—
—
—
—
—
—
39
6
447
5013
Extensive body CT
JN4BD [2001310899]
1.9e+00
—
—
—
—
-1.0e+50
2.4e+00
cases:1.49%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:2.47%
controls:0.24%
8
12
528
5277
—
—
—
—
0
6
518
5261
12
12
474
5007
Alcoholic cirrhosis of liver
K70.3 [45596343]
—
—
1.0e+50
1.0e+50
1.0e+50
—
4.2e+00
—
—
—
—
cases:1.12%
controls:0.00%
cases:2.24%
controls:0.00%
cases:1.71%
controls:0.00%
—
—
cases:7.20%
controls:0.12%
—
—
6
0
530
5289
12
0
524
5289
9
0
517
5289
—
35
6
451
5013
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
2.1e+00
—
—
—
—
—
2.1e+00
cases:1.49%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.34%
8
10
528
5279
—
—
—
—
—
13
17
473
5002
Osmolality of Urine
2695-5 [3026782]
1.2e+00
1.5e+00
—
—
—
1.7e+00
1.3e+00
cases:2.61%
controls:0.83%
cases:1.49%
controls:0.32%
—
—
—
—
—
—
cases:1.54%
controls:0.28%
cases:4.12%
controls:1.16%
14
44
522
5245
8
17
528
5272
—
—
—
8
15
510
5252
20
58
466
4961
tiotropium bromide; inhalant
R03BB04 [21603296]
1.6e+00
1.5e+00
—
—
—
1.1e+00
1.0e+00
cases:2.05%
controls:0.42%
cases:1.68%
controls:0.38%
—
—
—
—
—
—
cases:1.74%
controls:0.57%
cases:2.88%
controls:1.04%
11
22
525
5267
9
20
527
5269
—
—
—
9
30
509
5237
14
52
472
4967
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
1.3e+00
1.7e+00
—
—
—
—
1.1e+00
cases:2.61%
controls:0.70%
cases:1.49%
controls:0.28%
—
—
—
—
—
—
—
—
cases:3.70%
controls:1.24%
14
37
522
5252
8
15
528
5274
—
—
—
—
18
62
468
4957
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.8e-01
8.0e-01
1.3e+00
—
2.1e+00
1.2e+00
7.8e-01
cases:5.22%
controls:3.29%
cases:3.36%
controls:1.53%
cases:0.93%
controls:0.26%
—
—
cases:1.52%
controls:0.19%
cases:4.63%
controls:1.40%
cases:9.47%
controls:4.56%
28
174
508
5115
18
81
518
5208
5
14
531
5275
—
8
10
518
5279
24
74
494
5193
46
229
440
4790
Pain, unspecified
R52.9 [45544151]
—
2.3e+00
—
—
—
—
1.8e+00
—
—
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.38%
—
6
6
530
5283
—
—
—
—
11
19
475
5000
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
2.0e+00
—
—
—
—
—
2.1e+00
cases:1.12%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.26%
6
8
530
5281
—
—
—
—
—
10
13
476
5006
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.5e+00
—
—
—
—
2.3e+00
1.8e+00
cases:1.12%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.35%
controls:0.13%
cases:3.29%
controls:0.58%
6
13
530
5276
—
—
—
—
7
7
511
5260
16
29
470
4990
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
—
2.1e+00
—
—
—
1.8e+00
1.9e+00
—
—
cases:1.12%
controls:0.13%
—
—
—
—
—
—
cases:1.16%
controls:0.19%
cases:3.91%
controls:0.58%
—
6
7
530
5282
—
—
—
6
10
512
5257
19
29
467
4990
mianserin; oral
N06AX03 [21604732]
1.1e+00
1.9e+00
—
—
—
—
2.1e+00
cases:1.31%
controls:0.43%
cases:1.31%
controls:0.19%
—
—
—
—
—
—
—
—
cases:3.29%
controls:0.40%
7
23
529
5266
7
10
529
5279
—
—
—
—
16
20
470
4999
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
1.1e+00
1.7e+00
—
—
—
2.3e+00
1.2e+00
cases:1.68%
controls:0.57%
cases:1.49%
controls:0.26%
—
—
—
—
—
—
cases:1.54%
controls:0.15%
cases:1.85%
controls:0.54%
9
30
527
5259
8
14
528
5275
—
—
—
8
8
510
5259
9
27
477
4992
chlorprothixene; oral, parenteral
N05AF03 [21604533]
2.0e+00
—
—
—
—
1.4e+00
2.1e+00
cases:1.68%
controls:0.23%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.28%
cases:2.88%
controls:0.38%
9
12
527
5277
—
—
—
—
6
15
512
5252
14
19
472
5000
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
6.2e-01
1.1e+00
—
—
—
1.9e+00
1.0e+00
cases:3.36%
controls:1.83%
cases:2.43%
controls:0.81%
—
—
—
—
—
—
cases:3.67%
controls:0.55%
cases:6.79%
controls:2.57%
18
97
518
5192
13
43
523
5246
—
—
—
19
29
499
5238
33
129
453
4890
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.2e-01
5.0e-01
1.6e+00
—
1.9e+00
5.4e-01
2.0e-01
cases:10.82%
controls:8.13%
cases:10.26%
controls:6.50%
cases:5.97%
controls:1.27%
—
—
cases:6.08%
controls:0.96%
cases:11.58%
controls:7.06%
cases:16.67%
controls:14.05%
58
430
478
4859
55
344
481
4945
32
67
504
5222
—
32
51
494
5238
60
372
458
4895
81
705
405
4314
Nondependent abuse of drugs, Alcohol abuse
3050A [2000402898]
4.0e+00
1.0e+50
—
1.0e+50
—
1.0e+50
—
cases:5.04%
controls:0.09%
cases:3.17%
controls:0.00%
—
—
cases:1.31%
controls:0.00%
—
—
cases:1.16%
controls:0.00%
—
—
27
5
509
5284
17
0
519
5289
—
7
0
529
5289
—
6
0
512
5267
—
sucralfate; oral
A02BX02 [21600111]
1.6e+00
—
—
—
—
—
2.5e+00
cases:1.68%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.18%
9
19
527
5270
—
—
—
—
—
10
9
476
5010
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
8.0e-01
1.5e+00
—
—
—
1.5e+00
9.9e-01
cases:3.17%
controls:1.46%
cases:2.61%
controls:0.59%
—
—
—
—
—
—
cases:2.51%
controls:0.57%
cases:5.76%
controls:2.21%
17
77
519
5212
14
31
522
5258
—
—
—
13
30
505
5237
28
111
458
4908
Fracture of rib
S22.3 [45573285]
1.7e+00
—
—
—
—
—
2.3e+00
cases:1.68%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.26%
9
16
527
5273
—
—
—
—
—
12
13
474
5006
Gas panel - Venous blood
24339-4 [3000991]
1.3e+00
—
—
—
—
2.3e+00
1.6e+00
cases:0.93%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:2.26%
controls:0.46%
5
13
531
5276
—
—
—
—
6
6
512
5261
11
23
475
4996
gabapentin; oral
N02BF01 [955005]
6.9e-01
1.4e+00
—
—
—
1.5e+00
1.0e+00
cases:1.68%
controls:0.85%
cases:1.87%
controls:0.47%
—
—
—
—
—
—
cases:2.12%
controls:0.49%
cases:2.88%
controls:1.04%
9
45
527
5244
10
25
526
5264
—
—
—
11
26
507
5241
14
52
472
4967
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.2e+00
—
—
—
—
2.3e+00
1.5e+00
cases:1.68%
controls:0.53%
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.19%
cases:3.70%
controls:0.82%
9
28
527
5261
—
—
—
—
10
10
508
5257
18
41
468
4978
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
—
1.0e+50
—
—
—
—
3.9e+00
—
—
cases:1.12%
controls:0.00%
—
—
—
—
—
—
—
—
cases:6.17%
controls:0.14%
—
6
0
530
5289
—
—
—
—
30
7
456
5012
Alcohol dependence periodic alcoholism
F10.26 [2000501683]
—
—
—
—
—
—
3.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.17%
controls:0.14%
—
—
—
—
—
—
30
7
456
5012
Therapeutic discussion
SPAT1240 [2001700341]
1.7e+00
—
—
—
—
2.0e+00
2.2e+00
cases:1.49%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.13%
cases:2.67%
controls:0.32%
8
15
528
5274
—
—
—
—
5
7
513
5260
13
16
473
5003
Other chest pain
R07.3 [45597166]
2.0e+00
—
—
—
—
—
1.8e+00
cases:2.05%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:2.88%
controls:0.48%
11
15
525
5274
—
—
—
—
—
14
24
472
4995
cisapride; oral, rectal
A03FA02 [21600485]
2.1e+00
—
—
—
—
—
1.7e+00
cases:2.43%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.38%
13
16
523
5273
—
—
—
—
—
10
19
476
5000
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
2.4e-01
4.9e-01
1.6e+00
—
1.7e+00
4.9e-01
1.1e-01
cases:11.01%
controls:8.85%
cases:10.82%
controls:6.90%
cases:6.53%
controls:1.40%
—
—
cases:6.65%
controls:1.27%
cases:12.16%
controls:7.80%
cases:16.46%
controls:14.94%
59
468
477
4821
58
365
478
4924
35
74
501
5215
—
35
67
491
5222
63
411
455
4856
80
750
406
4269
Platelets [#/volume] in Blood
26515-7 [3007461]
2.4e-01
4.9e-01
1.6e+00
—
1.7e+00
4.9e-01
1.2e-01
cases:11.01%
controls:8.83%
cases:10.82%
controls:6.90%
cases:6.53%
controls:1.40%
—
—
cases:6.65%
controls:1.27%
cases:12.16%
controls:7.80%
cases:16.46%
controls:14.92%
59
467
477
4822
58
365
478
4924
35
74
501
5215
—
35
67
491
5222
63
411
455
4856
80
749
406
4270
Headache
R51.80 [2000503603]
7.7e-01
—
—
—
—
2.2e+00
1.6e+00
cases:0.93%
controls:0.43%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.13%
cases:2.26%
controls:0.46%
5
23
531
5266
—
—
—
—
6
7
512
5260
11
23
475
4996
Essential (primary) hypertension
I10 [45591453]
5.8e-01
6.8e-01
1.2e+00
1.0e+50
1.9e+00
6.9e-01
6.3e-01
cases:8.40%
controls:4.90%
cases:4.85%
controls:2.51%
cases:1.68%
controls:0.49%
cases:2.24%
controls:0.00%
cases:2.09%
controls:0.32%
cases:5.79%
controls:2.98%
cases:16.46%
controls:9.52%
45
259
491
5030
26
133
510
5156
9
26
527
5263
12
0
524
5289
11
17
515
5272
30
157
488
5110
80
478
406
4541
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
2.4e-01
4.9e-01
1.6e+00
—
1.7e+00
4.9e-01
1.1e-01
cases:11.01%
controls:8.89%
cases:10.82%
controls:6.90%
cases:6.53%
controls:1.40%
—
—
cases:6.65%
controls:1.30%
cases:12.16%
controls:7.78%
cases:16.46%
controls:14.98%
59
470
477
4819
58
365
478
4924
35
74
501
5215
—
35
69
491
5220
63
410
455
4857
80
752
406
4267
MCH [Entitic mass]
28539-5 [3035941]
2.4e-01
5.0e-01
1.6e+00
—
1.7e+00
4.9e-01
1.2e-01
cases:11.01%
controls:8.83%
cases:10.82%
controls:6.86%
cases:6.34%
controls:1.40%
—
—
cases:6.65%
controls:1.27%
cases:12.16%
controls:7.80%
cases:16.46%
controls:14.90%
59
467
477
4822
58
363
478
4926
34
74
502
5215
—
35
67
491
5222
63
411
455
4856
80
748
406
4271
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.4e-01
4.9e-01
1.6e+00
—
1.7e+00
4.9e-01
1.2e-01
cases:11.01%
controls:8.85%
cases:10.82%
controls:6.90%
cases:6.34%
controls:1.40%
—
—
cases:6.65%
controls:1.29%
cases:12.16%
controls:7.78%
cases:16.46%
controls:14.92%
59
468
477
4821
58
365
478
4924
34
74
502
5215
—
35
68
491
5221
63
410
455
4857
80
749
406
4270
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.4e-01
4.9e-01
1.5e+00
—
1.7e+00
5.1e-01
1.1e-01
cases:11.01%
controls:8.85%
cases:10.82%
controls:6.90%
cases:6.34%
controls:1.42%
—
—
cases:6.65%
controls:1.29%
cases:12.36%
controls:7.82%
cases:16.46%
controls:14.94%
59
468
477
4821
58
365
478
4924
34
75
502
5214
—
35
68
491
5221
64
412
454
4855
80
750
406
4269
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.4e-01
4.9e-01
1.6e+00
—
1.7e+00
4.9e-01
1.1e-01
cases:11.01%
controls:8.89%
cases:10.82%
controls:6.92%
cases:6.34%
controls:1.40%
—
—
cases:6.65%
controls:1.30%
cases:12.16%
controls:7.82%
cases:16.46%
controls:14.94%
59
470
477
4819
58
366
478
4923
34
74
502
5215
—
35
69
491
5220
63
412
455
4855
80
750
406
4269
Alcohol intoxication UNS
F10.09 [2000501676]
—
—
—
—
—
—
3.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.14%
—
—
—
—
—
—
27
7
459
5012
Alcohol dependence continuous use
F10.25 [2000501682]
3.7e+00
—
—
1.0e+50
—
1.0e+50
—
cases:3.73%
controls:0.09%
—
—
—
—
cases:0.93%
controls:0.00%
—
—
cases:3.28%
controls:0.00%
—
—
20
5
516
5284
—
—
5
0
531
5289
—
17
0
501
5267
—
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.6e-01
1.0e+00
—
—
—
2.1e+00
1.5e+00
cases:2.24%
controls:1.29%
cases:1.49%
controls:0.55%
—
—
—
—
—
—
cases:3.28%
controls:0.40%
cases:5.56%
controls:1.35%
12
68
524
5221
8
29
528
5260
—
—
—
17
21
501
5246
27
68
459
4951
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.9e+00
1.6e+00
—
1.0e+50
—
—
1.7e+00
cases:3.54%
controls:0.57%
cases:1.12%
controls:0.23%
—
—
cases:0.93%
controls:0.00%
—
—
—
—
cases:4.12%
controls:0.76%
19
30
517
5259
6
12
530
5277
—
5
0
531
5289
—
—
20
38
466
4981
Severe psychotic and other severe mental disorders
112 [2001600112]
1.5e+00
-1.0e+50
—
—
—
—
2.1e+00
cases:2.05%
controls:0.45%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.24%
11
24
525
5265
0
8
536
5281
—
—
—
—
9
12
477
5007
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
4.3e-01
1.3e+00
—
—
1.4e+00
1.1e+00
1.1e+00
cases:2.80%
controls:1.83%
cases:2.99%
controls:0.83%
—
—
—
—
cases:0.95%
controls:0.25%
cases:3.47%
controls:1.18%
cases:9.05%
controls:3.17%
15
97
521
5192
16
44
520
5245
—
—
5
13
521
5276
18
62
500
5205
44
159
442
4860
furosemide; oral, parenteral
C03CA01 [21601518]
7.7e-01
1.1e+00
1.0e+00
—
1.5e+00
1.1e+00
1.3e+00
cases:3.73%
controls:1.76%
cases:4.29%
controls:1.49%
cases:1.49%
controls:0.55%
—
—
cases:1.52%
controls:0.34%
cases:5.21%
controls:1.75%
cases:10.70%
controls:3.27%
20
93
516
5196
23
79
513
5210
8
29
528
5260
—
8
18
518
5271
27
92
491
5175
52
164
434
4855
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.4e+00
1.9e+00
—
—
—
—
2.1e+00
cases:2.43%
controls:0.61%
cases:1.12%
controls:0.17%
—
—
—
—
—
—
—
—
cases:5.56%
controls:0.74%
13
32
523
5257
6
9
530
5280
—
—
—
—
27
37
459
4982
Ammonium ion [Moles/volume] in Plasma
1845-7 [3023183]
—
—
—
—
—
—
3.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.12%
—
—
—
—
—
—
18
6
468
5013
Left side
ZXA05 [2001311347]
9.7e-01
—
-1.0e+50
—
—
2.5e+00
7.1e-01
cases:2.99%
controls:1.15%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.35%
controls:0.11%
cases:3.50%
controls:1.75%
16
61
520
5228
—
0
5
536
5284
—
—
7
6
511
5261
17
88
469
4931
Unspecified fall
W19 [45756257]
1.6e+00
—
—
—
—
—
1.9e+00
cases:1.68%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.60%
9
19
527
5270
—
—
—
—
—
18
30
468
4989
allopurinol; oral, parenteral
M04AA01 [21604131]
1.2e+00
1.3e+00
1.9e+00
—
—
8.6e-01
8.9e-01
cases:4.29%
controls:1.30%
cases:3.36%
controls:0.95%
cases:1.12%
controls:0.17%
—
—
—
—
cases:2.51%
controls:1.08%
cases:5.14%
controls:2.17%
23
69
513
5220
18
50
518
5239
6
9
530
5280
—
—
13
57
505
5210
25
109
461
4910
sertraline; oral
N06AB06 [21604714]
1.2e+00
1.7e+00
—
—
—
1.5e+00
1.7e+00
cases:2.24%
controls:0.68%
cases:2.05%
controls:0.38%
—
—
—
—
—
—
cases:1.54%
controls:0.36%
cases:4.12%
controls:0.82%
12
36
524
5253
11
20
525
5269
—
—
—
8
19
510
5248
20
41
466
4978
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
9.9e-01
8.1e-01
—
—
—
1.4e+00
9.4e-01
cases:2.80%
controls:1.06%
cases:1.31%
controls:0.59%
—
—
—
—
—
—
cases:2.32%
controls:0.57%
cases:3.70%
controls:1.47%
15
56
521
5233
7
31
529
5258
—
—
—
12
30
506
5237
18
74
468
4945
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.6e+00
—
—
—
—
—
1.7e+00
cases:1.49%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.48%
8
16
528
5273
—
—
—
—
—
13
24
473
4995
cefalexin; oral
J01DB01 [21602870]
7.0e-01
9.7e-01
1.2e+00
—
8.4e-01
7.4e-01
9.4e-01
cases:28.54%
controls:16.54%
cases:13.25%
controls:5.48%
cases:1.68%
controls:0.53%
—
—
cases:1.52%
controls:0.66%
cases:12.55%
controls:6.38%
cases:41.56%
controls:21.80%
153
875
383
4414
71
290
465
4999
9
28
527
5261
—
8
35
518
5254
65
336
453
4931
202
1094
284
3925
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
1.5e+00
1.5e+00
—
—
—
1.4e+00
1.9e+00
cases:2.43%
controls:0.57%
cases:1.31%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.25%
cases:4.12%
controls:0.66%
13
30
523
5259
7
16
529
5273
—
—
—
5
13
513
5254
20
33
466
4986
Bacterial pneumonia, unspecified
J15.9 [45557621]
1.8e+00
—
—
—
—
—
1.5e+00
cases:1.87%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.54%
10
16
526
5273
—
—
—
—
—
11
27
475
4992
Alcohol use
Z72.1 [45552103]
—
—
—
—
—
—
3.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.09%
controls:0.12%
—
—
—
—
—
—
15
6
471
5013
Atherosclerosis of arteries of extremities
I70.2 [45538421]
4.1e-01
—
—
—
—
1.8e+00
1.4e+00
cases:0.93%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.28%
cases:3.29%
controls:0.80%
5
33
531
5256
—
—
—
—
9
15
509
5252
16
40
470
4979
Guidance related to psychoactive substances / risk behaviour
SPAT1309 [2001700410]
—
1.0e+50
—
—
—
—
3.2e+00
—
—
cases:1.12%
controls:0.00%
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.10%
—
6
0
530
5289
—
—
—
—
12
5
474
5014
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.4e-01
9.2e-01
2.3e+00
—
—
6.6e-01
4.2e-01
cases:6.34%
controls:3.78%
cases:4.66%
controls:1.91%
cases:1.12%
controls:0.11%
—
—
—
—
cases:3.47%
controls:1.82%
cases:8.23%
controls:5.54%
34
200
502
5089
25
101
511
5188
6
6
530
5283
—
—
18
96
500
5171
40
278
446
4741
clidinium and psycholeptics
A03CA02 [21600204]
1.4e+00
—
—
—
—
—
1.8e+00
cases:2.61%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.62%
14
36
522
5253
—
—
—
—
—
18
31
468
4988
Gout, unspecified
M10.9 [45543454]
1.8e+00
—
—
—
—
—
1.3e+00
cases:1.31%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.64%
7
11
529
5278
—
—
—
—
—
11
32
475
4987
Urgent procedure
ZXD05 [2001311386]
4.3e-01
6.9e-01
—
—
—
1.7e+00
1.4e+00
cases:2.43%
controls:1.59%
cases:1.12%
controls:0.57%
—
—
—
—
—
—
cases:2.51%
controls:0.46%
cases:7.41%
controls:1.95%
13
84
523
5205
6
30
530
5259
—
—
—
13
24
505
5243
36
98
450
4921
Low back pain
M54.5 [45553207]
9.4e-01
1.3e+00
—
—
—
7.2e-01
8.4e-01
cases:3.54%
controls:1.42%
cases:2.05%
controls:0.55%
—
—
—
—
—
—
cases:1.54%
controls:0.76%
cases:5.35%
controls:2.39%
19
75
517
5214
11
29
525
5260
—
—
—
8
40
510
5227
26
120
460
4899
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.5e+00
—
—
—
—
1.6e+00
6.6e-01
cases:3.17%
controls:0.72%
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.36%
cases:2.06%
controls:1.08%
17
38
519
5251
—
—
—
—
9
19
509
5248
10
54
476
4965
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
1.7e+00
—
—
—
—
—
1.4e+00
cases:2.05%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.52%
11
21
525
5268
—
—
—
—
—
10
26
476
4993
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
5.0e-01
1.5e+00
—
—
—
1.5e+00
6.7e-01
cases:1.31%
controls:0.79%
cases:1.68%
controls:0.38%
—
—
—
—
—
—
cases:1.74%
controls:0.38%
cases:2.88%
controls:1.49%
7
42
529
5247
9
20
527
5269
—
—
—
9
20
509
5247
14
75
472
4944
Pneumonia, unspecified
J18.9 [45601123]
1.1e+00
1.9e+00
—
—
—
1.4e+00
6.8e-01
cases:2.61%
controls:0.89%
cases:2.05%
controls:0.30%
—
—
—
—
—
—
cases:1.35%
controls:0.34%
cases:3.91%
controls:2.01%
14
47
522
5242
11
16
525
5273
—
—
—
7
18
511
5249
19
101
467
4918
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.6e-01
3.2e-01
1.3e+00
—
1.8e+00
4.4e-01
5.0e-02
cases:7.65%
controls:6.62%
cases:6.72%
controls:4.97%
cases:3.17%
controls:0.93%
—
—
cases:4.94%
controls:0.89%
cases:8.30%
controls:5.51%
cases:11.93%
controls:11.42%
41
350
495
4939
36
263
500
5026
17
49
519
5240
—
26
47
500
5242
43
290
475
4977
58
573
428
4446
Suicide and self-inflicted poisoning by solid or liquid substances
E950A [2000409123]
3.0e+00
—
—
—
—
—
—
cases:1.87%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
10
5
526
5284
—
—
—
—
—
—
Cervical spine CT examination
NA1AD [2001306982]
2.3e+00
—
—
—
—
—
3.0e+00
cases:0.93%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.12%
5
5
531
5284
—
—
—
—
—
11
6
475
5013
Withdrawal symptoms caused by alcohol with seizures
F10.31 [2000501686]
—
—
—
—
—
1.0e+50
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.00%
cases:1.85%
controls:0.10%
—
—
—
—
—
5
0
513
5267
9
5
477
5014
UNS Panic Syndrome
F41.09 [2000501997]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.10%
—
—
—
—
—
—
9
5
477
5014
Neurology
13 [38004458]
8.5e-01
6.4e-01
—
—
1.3e+00
1.0e+00
1.1e+00
cases:9.89%
controls:4.50%
cases:3.54%
controls:1.91%
—
—
—
—
cases:1.14%
controls:0.30%
cases:5.79%
controls:2.20%
cases:15.43%
controls:5.88%
53
238
483
5051
19
101
517
5188
—
—
6
16
520
5273
30
116
488
5151
75
295
411
4724
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
4.8e-01
8.1e-01
1.1e+00
—
1.3e-01
7.6e-01
8.5e-01
cases:14.93%
controls:9.83%
cases:9.70%
controls:4.56%
cases:2.05%
controls:0.70%
—
—
cases:0.95%
controls:0.83%
cases:10.04%
controls:4.96%
cases:27.16%
controls:13.77%
80
520
456
4769
52
241
484
5048
11
37
525
5252
—
5
44
521
5245
52
261
466
5006
132
691
354
4328
hydrocortisone
S02BA01 [21605166]
7.1e-01
9.0e-01
—
—
—
1.1e+00
1.1e+00
cases:6.90%
controls:3.52%
cases:2.80%
controls:1.15%
—
—
—
—
—
—
cases:3.28%
controls:1.16%
cases:10.91%
controls:4.04%
37
186
499
5103
15
61
521
5228
—
—
—
17
61
501
5206
53
203
433
4816
ferrous glycine sulfate; oral
B03AA01 [21601080]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.14%
—
—
—
—
—
—
11
7
475
5012
venlafaxine; oral
N06AX16 [21604745]
1.4e+00
9.1e-01
—
—
—
9.4e-01
1.3e+00
cases:3.73%
controls:0.91%
cases:1.49%
controls:0.61%
—
—
—
—
—
—
cases:1.74%
controls:0.68%
cases:4.73%
controls:1.28%
20
48
516
5241
8
32
528
5257
—
—
—
9
36
509
5231
23
64
463
4955
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
2.8e+00
—
—
—
—
—
1.2e+00
cases:1.49%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.38%
8
5
528
5284
—
—
—
—
—
6
19
480
5000
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
2.8e+00
—
—
—
—
—
—
cases:1.49%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
8
5
528
5284
—
—
—
—
—
—
hydrocortisone aceponate
D07AC16 [21602135]
6.3e-01
8.4e-01
—
—
—
1.0e+00
1.1e+00
cases:7.28%
controls:4.01%
cases:2.99%
controls:1.30%
—
—
—
—
—
—
cases:3.86%
controls:1.42%
cases:12.14%
controls:4.48%
39
212
497
5077
16
69
520
5220
—
—
—
20
75
498
5192
59
225
427
4794
hydrocortisone buteprate
D07AB11 [21602115]
6.3e-01
8.4e-01
—
—
—
1.0e+00
1.1e+00
cases:7.28%
controls:4.01%
cases:2.99%
controls:1.30%
—
—
—
—
—
—
cases:3.86%
controls:1.42%
cases:12.14%
controls:4.48%
39
212
497
5077
16
69
520
5220
—
—
—
20
75
498
5192
59
225
427
4794
hydrocortisone
D07AA02 [21602102]
6.3e-01
8.4e-01
—
—
—
1.0e+00
1.1e+00
cases:7.28%
controls:4.01%
cases:2.99%
controls:1.30%
—
—
—
—
—
—
cases:3.86%
controls:1.42%
cases:12.14%
controls:4.48%
39
212
497
5077
16
69
520
5220
—
—
—
20
75
498
5192
59
225
427
4794
hydrocortisone butyrate
D07AB02 [21602106]
6.3e-01
8.4e-01
—
—
—
1.0e+00
1.1e+00
cases:7.28%
controls:4.01%
cases:2.99%
controls:1.30%
—
—
—
—
—
—
cases:3.86%
controls:1.42%
cases:12.14%
controls:4.48%
39
212
497
5077
16
69
520
5220
—
—
—
20
75
498
5192
59
225
427
4794
Catheterisation of bladder
TKC20 [2001306020]
1.4e+00
—
—
—
—
—
2.7e+00
cases:0.93%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.18%
5
12
531
5277
—
—
—
—
—
13
9
473
5010
Person consulting for explanation of investigation findings
Z71.2 [45552100]
1.1e+00
1.2e+00
—
—
—
1.6e+00
1.1e+00
cases:2.24%
controls:0.79%
cases:1.31%
controls:0.42%
—
—
—
—
—
—
cases:1.93%
controls:0.38%
cases:3.91%
controls:1.37%
12
42
524
5247
7
22
529
5267
—
—
—
10
20
508
5247
19
69
467
4950
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.14%
—
—
—
—
—
—
10
7
476
5012
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
1.4e+00
1.7e+00
—
—
—
—
1.3e+00
cases:2.61%
controls:0.66%
cases:1.12%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.76%
14
35
522
5254
6
11
530
5278
—
—
—
—
13
38
473
4981
Unspecified diabetes mellitus, without complications
E14.9 [45605408]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.12%
—
—
—
—
—
—
8
6
478
5013
Treatment plan or consultation
WZC00 [2001310885]
6.9e-01
—
—
—
—
1.7e+00
8.9e-01
cases:2.05%
controls:1.04%
—
—
—
—
—
—
—
—
cases:2.32%
controls:0.42%
cases:4.32%
controls:1.81%
11
55
525
5234
—
—
—
—
12
22
506
5245
21
91
465
4928
Chronic apical periodontitis
K04.5 [45586691]
9.9e-01
1.6e+00
—
—
—
1.3e+00
3.8e-01
cases:2.80%
controls:1.06%
cases:1.68%
controls:0.34%
—
—
—
—
—
—
cases:1.54%
controls:0.42%
cases:2.47%
controls:1.69%
15
56
521
5233
9
18
527
5271
—
—
—
8
22
510
5245
12
85
474
4934
Melaena
K92.1 [45533624]
—
—
1.0e+50
1.0e+50
—
—
2.6e+00
—
—
—
—
cases:0.93%
controls:0.00%
cases:1.12%
controls:0.00%
—
—
—
—
cases:3.09%
controls:0.24%
—
—
5
0
531
5289
6
0
530
5289
—
—
15
12
471
5007
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
—
—
1.0e+50
—
—
—
2.6e+00
—
—
—
—
cases:1.49%
controls:0.00%
—
—
—
—
—
—
cases:3.50%
controls:0.28%
—
—
8
0
528
5289
—
—
—
17
14
469
5005
Social worker
Z2446 [2001311559]
1.7e+00
—
—
—
—
—
2.6e+00
cases:1.12%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.18%
6
11
530
5278
—
—
—
—
—
11
9
475
5010
General medical examination
Z00.0 [45585791]
1.3e+00
—
—
—
—
—
1.2e+00
cases:2.24%
controls:0.61%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:1.12%
12
32
524
5257
—
—
—
—
—
18
56
468
4963
Superficial injury of scalp
S00.0 [45548998]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.10%
—
—
—
—
—
—
6
5
480
5014
Appendicectomy
6421 [2000100987]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.10%
0
14
536
5275
—
—
—
—
—
6
5
480
5014
Tobacco use
Z72.0 [45581063]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.10%
—
—
—
—
—
—
6
5
480
5014
Fracture of lateral malleolus
S82.6 [45569819]
1.6e+00
—
—
—
—
—
2.5e+00
cases:0.93%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:2.67%
controls:0.22%
5
10
531
5279
—
—
—
—
—
13
11
473
5008
Erysipelas
A46 [45561706]
1.2e+00
—
—
—
—
—
1.3e+00
cases:2.24%
controls:0.66%
—
—
—
—
—
—
—
—
—
—
cases:4.53%
controls:1.30%
12
35
524
5254
—
—
—
—
—
22
65
464
4954
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
1.2e+00
1.5e+00
—
1.0e+50
—
2.5e+00
9.6e-01
cases:2.24%
controls:0.68%
cases:1.49%
controls:0.34%
—
—
cases:1.12%
controls:0.00%
—
—
cases:2.51%
controls:0.21%
cases:2.47%
controls:0.96%
12
36
524
5253
8
18
528
5271
—
6
0
530
5289
—
13
11
505
5256
12
48
474
4971
magnesium hydroxide; oral
G04BX01 [21602658]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.12%
—
—
—
—
—
—
7
6
479
5013
magnesium hydroxide; oral
A02AA04 [21600052]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.12%
—
—
—
—
—
—
7
6
479
5013
Unspecified kidney failure
N19 [45601718]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.12%
—
—
—
—
—
—
7
6
479
5013
trazodone; oral
N06AX05 [21604734]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.14%
—
—
—
—
—
—
8
7
478
5012
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
2.5e+00
—
—
—
—
—
—
cases:1.12%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
530
5284
—
—
—
—
—
—
Bipolar affective disorder
F31 [45595902]
2.5e+00
—
—
—
—
—
—
cases:1.12%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
530
5284
—
—
—
—
—
—
General medical examination, Routine general medical examination at a health care facility
V700A [2000409207]
2.5e+00
—
—
—
—
—
—
cases:1.12%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
530
5284
—
—
—
—
—
—
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.16%
—
—
—
—
—
—
9
8
477
5011
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
2.5e+00
—
—
—
—
—
—
cases:1.31%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
529
5283
—
—
—
—
—
—
More than one and less than three hours
ZXE10 [2001311401]
3.7e-01
—
—
—
—
1.4e+00
9.6e-01
cases:2.99%
controls:2.08%
—
—
—
—
—
—
—
—
cases:2.12%
controls:0.51%
cases:6.38%
controls:2.55%
16
110
520
5179
—
—
—
—
11
27
507
5240
31
128
455
4891
Medical doctor
Z2221 [2001311556]
1.2e+00
1.1e+00
—
1.0e+50
—
1.2e+00
1.2e+00
cases:3.54%
controls:1.13%
cases:1.68%
controls:0.55%
—
—
cases:1.87%
controls:0.00%
—
—
cases:1.93%
controls:0.57%
cases:4.73%
controls:1.43%
19
60
517
5229
9
29
527
5260
—
10
0
526
5289
—
10
30
508
5237
23
72
463
4947
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
8.3e-01
1.5e+00
—
—
—
—
2.4e+00
cases:1.12%
controls:0.49%
cases:0.93%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.22%
6
26
530
5263
5
11
531
5278
—
—
—
—
11
11
475
5008
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.22%
—
—
—
—
—
—
11
11
475
5008
FEV1/FVC
19926-5 [3011505]
8.3e-01
1.5e+00
—
—
—
—
2.4e+00
cases:1.12%
controls:0.49%
cases:0.93%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.22%
6
26
530
5263
5
11
531
5278
—
—
—
—
11
11
475
5008
FEV1
20150-9 [3024653]
8.3e-01
1.5e+00
—
—
—
—
2.4e+00
cases:1.12%
controls:0.49%
cases:0.93%
controls:0.21%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.22%
6
26
530
5263
5
11
531
5278
—
—
—
—
11
11
475
5008
FEV1 --post bronchodilation
20155-8 [3023550]
1.0e+00
—
—
—
—
—
2.4e+00
cases:1.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
6
22
530
5267
—
—
—
—
—
9
9
477
5010
FEV1 percent change
69983-5 [42868472]
1.0e+00
—
—
—
—
—
2.4e+00
cases:1.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
6
22
530
5267
—
—
—
—
—
9
9
477
5010
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.0e+00
—
—
—
—
—
2.4e+00
cases:1.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
6
22
530
5267
—
—
—
—
—
9
9
477
5010
FVC percent change Respiratory system
69982-7 [42868471]
1.0e+00
—
—
—
—
—
2.4e+00
cases:1.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
6
22
530
5267
—
—
—
—
—
9
9
477
5010
Dysthymia
F34.1 [45586238]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
—
—
—
—
—
—
9
9
477
5010
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.0e+00
—
—
—
—
—
2.4e+00
cases:1.12%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.18%
6
22
530
5267
—
—
—
—
—
9
9
477
5010
Psychosocial counselling and guidance
SPAT1307 [2001700408]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.16%
—
—
—
—
—
—
8
8
478
5011
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.10%
—
—
—
—
—
—
5
5
481
5014
Gastroscopy
UJD02 [2001304787]
—
1.0e+50
—
1.0e+50
1.0e+50
—
2.3e+00
—
—
cases:1.31%
controls:0.00%
—
—
cases:0.93%
controls:0.00%
cases:1.33%
controls:0.00%
—
—
cases:1.03%
controls:0.10%
—
7
0
529
5289
—
5
0
531
5289
7
0
519
5289
—
5
5
481
5014
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.10%
—
—
—
—
—
—
5
5
481
5014
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.10%
—
—
—
—
—
—
5
5
481
5014
Fever, unspecified
R50.9 [45582716]
—
1.5e+00
—
—
—
2.3e+00
2.8e-01
—
—
cases:0.93%
controls:0.21%
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:1.03%
controls:0.78%
—
5
11
531
5278
—
—
—
6
6
512
5261
5
39
481
4980
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
1.6e+00
—
—
—
—
2.3e+00
1.4e+00
cases:0.93%
controls:0.19%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:2.06%
controls:0.54%
5
10
531
5279
—
—
—
—
6
6
512
5261
10
27
476
4992
General anaesthesia
WX402 [2001310806]
1.2e+00
—
—
—
—
2.3e+00
8.3e-01
cases:1.31%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.11%
cases:1.85%
controls:0.82%
7
21
529
5268
—
—
—
—
6
6
512
5261
9
41
477
4978
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
—
—
—
—
—
2.3e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.44%
controls:0.30%
—
—
—
—
—
5
5
513
5262
7
15
479
5004
Diabetes, insulin-treated
103 [2001600103]
9.7e-01
1.5e+00
—
—
—
—
1.3e+00
cases:4.29%
controls:1.66%
cases:1.12%
controls:0.26%
—
—
—
—
—
—
—
—
cases:7.00%
controls:1.93%
23
88
513
5201
6
14
530
5275
—
—
—
—
34
97
452
4922
pregabalin; oral
N02BF02 [955152]
1.0e+00
1.1e+00
—
—
1.7e+00
1.1e+00
1.3e+00
cases:3.17%
controls:1.13%
cases:1.87%
controls:0.61%
—
—
—
—
cases:1.14%
controls:0.21%
cases:1.93%
controls:0.63%
cases:5.56%
controls:1.65%
17
60
519
5229
10
32
526
5257
—
—
6
11
520
5278
10
33
508
5234
27
83
459
4936
Feeling depressed
P03 [2002000800]
2.3e+00
—
—
—
—
—
1.6e+00
cases:1.31%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.26%
7
7
529
5282
—
—
—
—
—
6
13
480
5006
trimipramine; oral, parenteral
N06AA06 [21604693]
2.3e+00
—
—
—
—
—
2.0e+00
cases:1.31%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.14%
7
7
529
5282
—
—
—
—
—
5
7
481
5012
Sleep disturbance
P06 [2002000803]
2.3e+00
—
—
—
—
—
1.2e+00
cases:1.31%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.48%
7
7
529
5282
—
—
—
—
—
8
24
478
4995
Hypo-osmolality and hyponatraemia
E87.1 [45542779]
2.3e+00
—
—
—
—
—
—
cases:1.31%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
529
5282
—
—
—
—
—
—
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
1.7e+00
2.3e+00
—
—
—
—
5.5e-01
cases:0.93%
controls:0.17%
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.60%
5
9
531
5280
6
6
530
5283
—
—
—
—
5
30
481
4989
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2.3e+00
—
—
—
—
—
—
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
530
5283
—
—
—
—
—
—
Mixed personality disorders
F61.0 [2000502024]
2.3e+00
—
—
—
—
—
1.8e+00
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.18%
6
6
530
5283
—
—
—
—
—
5
9
481
5010
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
2.3e+00
—
—
—
—
—
—
cases:1.12%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
530
5283
—
—
—
—
—
—
Amphetamines [Presence] in Urine
3349-8 [3027944]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.24%
—
—
—
—
—
—
11
12
475
5007
haloperidol; oral, parenteral
N05AD01 [21604516]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.18%
—
—
—
—
—
—
8
9
478
5010
Pain in limb
M79.6 [45587063]
9.2e-01
1.4e+00
-1.0e+50
—
—
1.2e+00
8.5e-01
cases:3.17%
controls:1.29%
cases:2.05%
controls:0.53%
cases:0.00%
controls:0.11%
—
—
—
—
cases:2.12%
controls:0.63%
cases:6.17%
controls:2.73%
17
68
519
5221
11
28
525
5261
0
6
536
5283
—
—
11
33
507
5234
30
137
456
4882
Cutaneous abscess, furuncle and carbuncle of limb
L02.4 [45552967]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.16%
—
—
—
—
—
—
7
8
479
5011
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.16%
—
—
—
—
—
—
7
8
479
5011
clomipramine; oral, parenteral
N06AA04 [21604691]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.14%
—
—
—
—
—
—
6
7
480
5012
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.14%
—
—
—
—
—
—
6
7
480
5012
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.26%
—
—
—
—
—
—
11
13
475
5006

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
95
123
9.09
71.03
4.0
2.7
33.05
41.99
umol/l
0.67
87
114
117
221
6.42
61.81
3.0
1.7
0.45
0.33
mg/l
1.23
78
120
49
39
13.67
50.96
2.7
1.4
1.89
0.98
promille
2.17
41
32
45
34
14.30
48.18
2.2
1.9
—
—
—
0
0
130
375
4.21
40.81
1.5
1.2
—
—
—
0
0
287
1398
3.15
39.30
6.3
2.7
60.46
61.10
u/l
0.05
273
1307
138
458
3.67
35.06
3.9
2.1
0.18
0.21
g/l
3.36
122
421
60
105
6.28
33.58
1.5
1.4
246.41
257.47
ug/g
0.11
32
58
196
850
3.00
31.65
5.2
3.7
0.76
0.82
mmol/l
8.16
190
806
145
535
3.30
30.84
5.2
2.9
12.27
10.08
umol/l
0.46
133
492
159
648
3.03
28.28
5.9
6.9
0.98
1.03
mmol/l
1.58
153
605
53
97
5.93
28.26
2.2
1.4
—
—
—
0
0
380
2453
2.69
26.56
14.2
7.5
13.56
12.82
umol/l
0.36
363
2362
53
104
5.52
26.23
2.2
1.4
—
—
—
0
0
148
602
2.98
26.21
12.0
8.5
0.64
0.74
mmol/l
0.10
130
507
53
108
5.31
25.15
2.1
1.4
—
—
—
0
0
53
108
5.31
25.15
2.2
1.4
—
—
—
0
0
146
608
2.89
24.62
12.0
8.4
10.94
12.07
kpa
2.48
141
590
145
606
2.88
24.25
12.2
8.5
7.42
7.42
ph
0.06
83
333
116
436
3.09
23.40
6.1
2.4
26.35
43.94
u/l
1.06
102
371
258
1449
2.44
23.35
5.9
4.7
—
—
—
0
0
211
1087
2.51
23.02
2.7
2.0
3.26
2.91
mg/l
1.11
180
931
50
107
5.03
22.41
2.2
1.4
—
—
—
0
0
123
513
2.79
20.34
13.1
9.4
121.51
122.76
g/l
0.22
123
504
91
321
3.19
20.30
12.7
9.4
24.08
24.68
mmol/l
0.78
91
321
155
729
2.55
20.13
3.0
2.6
2.23
2.26
g/l
0.16
143
681
55
139
4.28
20.07
1.2
1.2
85.71
100.67
titre
—
7
15
265
1596
2.25
19.40
7.4
3.4
40.19
47.13
u/l
0.30
253
1509
112
457
2.81
19.23
7.9
8.0
9.05
10.76
mmol/l
1.68
106
436
161
787
2.46
19.14
3.0
2.6
12.91
13.70
umol/l
0.64
147
737
145
679
2.53
18.87
3.1
2.7
24.31
24.32
%
0.00
136
636
316
2078
2.19
18.19
12.3
7.1
1.18
1.20
mmol/l
5.99
310
1917
144
688
2.47
17.85
2.1
1.7
1308.61
1168.03
nmol/l
0.82
108
536
312
2057
2.16
17.65
8.8
5.2
33.34
35.52
g/l
7.36
300
1940
28
21
13.97
16.64
1.8
1.6
93.30
71.67
umol/l
—
10
12
124
573
2.49
16.39
2.0
2.8
2.09
1.78
%
1.65
112
522
103
439
2.65
16.08
16.7
9.8
—
—
—
0
0
336
2330
2.10
16.04
12.8
7.6
1.18
1.20
mmol/l
5.71
309
2004
82
311
2.92
15.98
6.7
4.9
—
—
—
0
0
339
2373
2.08
15.59
20.4
14.9
1.27
1.28
inr
0.12
282
1960
107
475
2.55
15.32
7.0
3.8
1.16
1.81
mmol/l
0.79
94
406
144
734
2.29
15.15
13.0
7.6
103.63
104.33
mmol/l
0.83
144
734
109
499
2.47
14.58
7.0
3.8
7.37
7.38
ph
0.49
72
289
101
1935
0.42
14.43
5.0
3.3
—
—
—
0
0
77
302
2.80
14.05
11.6
11.2
15.90
16.19
%
0.34
77
292
19
8
24.51
13.87
1.9
1.0
—
—
—
0
0
389
4632
0.48
13.38
6.0
5.3
4.26
4.53
mmol/l
5.40
365
4325
386
4608
0.48
13.37
5.9
5.2
1.31
1.37
mmol/l
2.36
363
4269
234
1513
1.94
12.66
3.6
2.6
—
—
—
0
0
96
441
2.42
12.65
2.3
3.0
78.21
67.85
e9/l
1.54
70
324
233
1510
1.93
12.47
4.1
2.1
325.79
255.92
u/l
0.35
227
1435
402
4704
0.49
12.12
6.8
6.0
2.42
2.66
mmol/l
6.02
376
4383
160
922
2.03
11.96
3.5
2.8
463.19
565.13
mosm/kgh2o
7.12
141
808
208
1315
1.92
11.86
2.0
1.7
16.37
19.50
nmol/l
3.35
191
1106
194
1202
1.94
11.73
10.9
4.3
80.98
87.25
%
2.72
188
1189
73
306
2.59
11.64
1.4
1.9
1.49
1.54
g/l
0.08
68
284
443
5001
0.46
11.50
55.7
24.5
129.66
139.00
g/l
23.95
438
4946
443
4999
0.47
11.40
54.7
24.2
30.76
30.58
pg
1.12
437
4946
443
4999
0.47
11.40
55.0
24.4
7.35
6.85
e9/l
4.29
433
4885
443
4999
0.47
11.40
56.9
24.9
38.75
41.16
%
14.79
437
4941
443
4999
0.47
11.40
54.9
24.3
4.27
4.58
e12/l
20.60
433
4885
443
4997
0.47
11.30
54.8
24.3
92.33
91.47
fl
2.99
437
4944
443
4997
0.47
11.30
55.2
24.4
238.38
239.31
e9/l
0.09
434
4897
133
733
2.07
11.14
2.8
2.1
—
—
—
0
0
32
84
3.98
11.08
1.9
1.3
47.43
60.90
mmol/l
1.06
21
70
74
321
2.50
10.98
8.5
7.0
24.75
24.55
mmol/l
0.17
74
307
97
484
2.21
10.45
1.8
1.7
—
—
—
0
0
211
1389
1.83
10.29
6.2
4.8
7.40
7.40
ph
1.08
169
983
229
1552
1.80
10.10
6.7
6.4
—
—
—
0
0
19
19
10.31
10.08
3.4
1.9
293.42
902.79
e6/l
0.77
12
14
82
388
2.30
10.01
2.0
2.5
11.68
10.84
g/l
1.04
77
358
279
2015
1.76
9.82
2.7
2.1
89.37
94.88
pmol/l
1.33
175
1114
375
4420
0.55
9.77
5.0
4.5
1.40
1.36
mmol/l
0.40
345
4077
263
1875
1.76
9.62
7.7
3.8
26.67
78.03
ng/l
1.12
216
1428
67
297
2.43
9.47
3.9
4.7
114.44
93.80
ng/l
0.51
57
260
22
49
4.63
9.38
1.2
1.4
274.44
283.89
mosm/kgh2o
0.67
16
37
131
771
1.91
8.91
1.5
1.5
3.78
2.80
g/l
3.88
93
503
28
80
3.63
8.63
1.0
1.1
—
—
—
0
0
108
602
1.98
8.60
1.8
1.7
—
—
—
0
0
335
2604
1.71
8.60
10.9
10.7
4.59
4.22
e9/l
1.79
297
2259
175
1139
1.78
8.57
3.8
2.9
—
—
—
0
0
360
2857
1.72
8.52
12.5
5.3
7.29
6.81
mmol/l
2.95
353
2742
35
117
3.12
8.46
2.2
2.4
120.54
128.91
g/l
0.77
26
100
443
4927
0.53
8.23
48.1
21.3
82.57
83.40
umol/l
0.15
437
4886
96
523
2.01
8.13
1.9
1.6
—
—
—
0
0
16
18
9.11
8.08
3.1
1.6
481.13
6188.90
e6/l
—
8
10
15
15
10.24
8.07
2.6
1.6
—
—
—
0
0
101
563
1.97
8.01
1.8
1.8
—
—
—
0
0
256
1885
1.66
7.81
3.8
2.8
181.58
183.43
ug/l
0.03
239
1760
286
2171
1.65
7.70
4.1
2.8
—
—
estimate
—
0
0
76
394
2.07
7.35
1.5
3.4
66.52
66.70
g/l
0.06
71
364
282
2159
1.61
7.15
7.4
6.7
9.13
9.21
%
0.15
268
2037
440
4873
0.56
7.13
23.8
12.2
31.51
28.97
u/l
1.25
428
4741
18
30
6.16
7.13
1.1
1.0
—
—
—
0
0
280
2150
1.60
6.95
7.5
6.6
2.80
2.85
%
0.16
266
2030
144
939
1.72
6.80
1.9
1.7
475.05
31673470.29
pmol/l
0.97
121
783
66
337
2.09
6.64
6.0
3.8
7.41
7.42
ph
0.26
58
280
127
805
1.75
6.62
3.9
3.2
2.16
0.90
e6/l
0.96
71
421
279
2159
1.58
6.57
7.4
6.5
58.84
57.78
%
0.79
267
2073
417
3556
1.67
6.47
17.2
8.7
95.02
80.23
u/l
3.49
403
3381
277
2154
1.56
6.30
7.6
6.6
0.65
0.68
%
0.38
263
2032
147
982
1.67
6.29
2.0
1.7
1.45
1.33
mg/l
0.16
123
778
9
5
18.26
6.28
2.3
1.4
—
—
mmol/l
—
0
0
9
5
18.26
6.28
2.3
1.4
—
—
mmol/l
—
0
0
193
1383
1.60
6.23
4.6
3.2
0.90
0.50
e6/l
0.56
154
1025
28
99
2.92
6.19
7.3
6.4
8.70
8.58
kpa
0.13
28
99
28
99
2.92
6.19
7.3
6.4
5.21
5.14
kpa
0.15
28
99
41
178
2.41
6.08
4.1
4.0
1.30
1.38
mmol/l
0.21
41
173
160
1105
1.63
5.97
3.4
2.6
5.30
4.11
e6/l
0.45
147
1013
217
1611
1.56
5.97
4.7
3.3
24.27
61.95
e6/l
1.71
175
1243
402
4516
0.62
5.96
6.1
5.2
6.61
6.09
mmol/l
5.38
374
4149
351
2900
1.56
5.94
6.5
4.1
26.67
429.00
e6/l
—
6
54
14
22
6.50
5.89
1.1
1.4
162.64
152.56
nmol/l
0.16
14
22
24
80
3.09
5.87
1.0
1.1
—
—
—
0
0
30
115
2.70
5.73
5.0
4.7
—
—
—
0
0
138
929
1.64
5.67
8.0
3.9
446.97
512.10
ng/l
0.09
122
764
179
1284
1.58
5.66
4.7
3.2
—
0.00
estimate
—
0
7
14
24
5.95
5.56
1.1
1.0
—
—
—
0
0
277
2194
1.52
5.55
7.6
6.7
24.93
26.82
%
2.37
267
2094
48
233
2.16
5.51
6.8
4.1
—
—
—
0
0
300
2420
1.51
5.48
7.4
6.7
0.20
0.20
e9/l
0.04
260
2101
28
108
2.68
5.30
9.7
7.5
103.14
105.08
mmol/l
0.90
28
100
28
108
2.68
5.30
9.7
7.5
12.32
11.20
mmol/l
0.55
28
100
401
4479
0.64
5.28
9.6
6.6
42.75
39.94
mmol/mol
4.07
381
4211
72
411
1.86
5.27
1.9
2.5
333.08
379.60
nmol/l
1.35
66
388
371
3146
1.53
5.23
10.3
3.3
110.49
56.92
u/l
6.45
353
2977
207
1557
1.52
5.21
3.9
3.3
1511.69
1357.83
ng/l
0.21
180
1345
290
2347
1.49
5.06
7.1
6.5
0.64
0.62
e9/l
0.75
250
2003
48
241
2.08
5.06
1.5
1.8
1.54
1.53
g/l
0.03
38
213
34
148
2.38
5.04
7.4
5.2
7.42
7.41
ph
0.54
34
148
290
2351
1.48
5.00
7.2
6.5
0.04
0.04
e9/l
0.36
253
2010
80
482
1.77
4.91
2.9
5.1
13.63
19.43
ug/l
0.19
72
397
15
33
4.64
4.90
2.5
1.2
—
—
—
0
0
125
1753
0.63
4.86
3.4
3.1
0.74
0.74
ug/l
0.00
94
1111
73
434
1.78
4.69
1.6
2.3
144.52
122.29
ug/g
0.44
61
359
291
2386
1.45
4.58
7.3
6.6
1.80
2.05
e9/l
1.45
257
2098
229
1802
1.46
4.44
3.9
3.4
6.72
8.46
mmol/l
7.04
195
1534
120
825
1.58
4.44
1.5
1.2
2.70
1.54
u/ml
0.39
34
257
10
16
6.34
4.31
3.7
2.4
0.61
0.58
mmol/l
—
10
16
440
4773
0.64
4.28
49.0
19.5
3.99
4.01
mmol/l
0.86
432
4682
29
127
2.35
4.27
4.6
3.9
2.28
1.88
index
0.11
22
81
23
91
2.59
4.18
1.3
1.2
333.25
258.88
u/ml
0.43
16
52
17
57
3.04
4.15
3.6
2.0
11.64
10.33
%
0.58
17
57
25
104
2.47
4.11
1.2
1.8
—
—
—
0
0
193
1494
1.44
3.99
3.2
3.7
2.34
2.35
mmol/l
0.33
178
1362
10
18
5.63
3.99
4.1
5.1
—
—
—
0
0
224
1783
1.43
3.97
5.6
3.9
44.43
62.18
e6/l
0.51
177
1293
179
1369
1.45
3.94
7.1
6.7
—
—
—
0
0
17
59
2.94
3.93
2.9
2.2
86.98
89.19
%
0.74
17
59
440
4757
0.66
3.92
49.0
19.3
138.40
139.77
mmol/l
15.78
433
4674
55
321
1.79
3.77
1.3
1.6
—
—
—
0
0
53
308
1.80
3.69
1.6
3.1
—
—
—
0
0
240
2865
0.72
3.65
5.3
5.2
2.23
2.33
ug/l
0.12
219
2588
19
74
2.62
3.58
2.0
2.5
35.11
33.23
pg
0.93
19
74
20
80
2.56
3.58
1.6
1.6
154.67
154.24
au/ml
—
6
21
65
405
1.68
3.55
6.0
4.4
7.36
7.35
ph
0.14
50
291
25
113
2.27
3.46
1.2
1.4
0.53
0.88
nmol/l
1.92
20
98
230
1873
1.39
3.46
3.0
2.3
69.16
75.63
nmol/l
2.85
209
1671
38
203
1.94
3.44
1.2
1.2
—
—
—
0
0
14
47
3.03
3.43
1.0
1.2
—
—
—
0
0
26
121
2.20
3.37
1.2
1.2
—
—
—
0
0
36
194
1.91
3.19
3.1
4.0
11806.19
7150.66
u/ml
0.15
31
161
88
607
1.53
3.18
1.5
1.5
—
—
—
0
0
17
68
2.55
3.07
1.4
1.6
—
—
—
0
0
17
68
2.55
3.07
1.4
1.6
—
—
—
0
0
17
68
2.55
3.07
1.4
1.6
—
—
—
0
0
17
68
2.55
3.07
1.4
1.6
—
—
—
0
0
36
201
1.85
2.88
1.5
1.7
—
—
—
0
0
7
13
5.44
2.87
2.7
4.2
5.71
6.22
ug/l
—
7
13
228
1908
1.33
2.71
4.3
3.1
6.27
6.15
ph
0.85
131
1071
12
41
2.97
2.63
1.3
1.1
—
—
—
0
0
12
42
2.90
2.56
1.1
1.1
—
—
—
0
0
40
240
1.72
2.55
2.0
2.0
3.18
1.73
ug/l
0.39
34
218
7
16
4.42
2.48
1.0
1.0
—
—
—
0
0
7
16
4.42
2.48
1.0
1.1
—
—
—
0
0
20
97
2.10
2.40
1.2
1.3
—
—
—
0
0
5
8
6.29
2.37
1.2
1.6
3.20
2.25
%
—
5
8
211
1773
1.30
2.37
5.0
4.2
11.72
7.70
mg/mmol
0.73
138
1161
208
1746
1.30
2.35
4.0
3.5
60.80
47.86
mg/l
0.36
145
1182
81
586
1.45
2.34
1.4
1.3
222.50
465.25
titre
2.71
16
122
6
13
4.65
2.27
1.2
1.6
—
—
—
0
0
114
882
1.37
2.24
3.3
3.3
2.46
2.45
mmol/l
0.70
102
806
55
371
1.53
2.23
3.5
3.2
211.58
200.96
ng/l
0.06
50
341
20
101
2.02
2.18
1.4
1.3
2.40
50.28
e6/l
0.81
15
74
14
62
2.29
2.09
4.1
2.3
11.93
10.62
mmol/l
0.26
14
62
30
177
1.73
2.06
2.2
2.3
—
—
—
0
0
5
144
0.34
2.04
1.0
1.1
1.50
1.49
g/l
—
5
144
0
51
0.00
1.89
0.0
2.4
—
—
—
0
0
9
34
2.67
1.87
1.3
1.2
—
—
—
0
0
41
271
1.55
1.85
1.2
1.2
—
—
—
0
0
5
12
4.19
1.82
1.2
2.0
—
—
—
0
0
16
80
2.03
1.81
1.1
1.3
0.83
0.83
g/l
—
10
61
20
109
1.87
1.79
1.4
1.1
—
—
—
0
0
15
75
2.03
1.71
1.5
2.7
—
—
—
0
0
8
174
0.45
1.60
1.4
1.6
—
—
—
0
0
6
20
3.02
1.58
1.7
1.8
—
—
—
0
0
9
181
0.49
1.53
1.1
1.2
—
—
—
0
0
18
102
1.79
1.46
2.9
2.9
0.72
0.86
nmol/l
0.81
13
85
65
497
1.35
1.41
1.4
1.4
—
—
—
0
0
126
1054
1.25
1.40
4.9
3.5
1.02
1.02
kg/l
2.92
83
702
12
61
1.99
1.33
1.6
1.5
—
—
—
0
0
19
305
0.61
1.32
1.2
1.4
—
—
—
0
0
0
41
0.00
1.31
0.0
1.3
—
140.55
—
0
41
6
25
2.41
1.24
3.7
2.6
—
—
—
0
0
12
64
1.89
1.19
1.3
1.2
—
—
—
0
0
8
39
2.07
1.15
1.3
1.3
—
—
—
0
0
54
416
1.33
1.14
1.4
1.5
—
—
—
0
0
22
143
1.56
1.13
2.4
2.4
174.57
89.76
ug/min
—
7
78
55
428
1.32
1.09
4.3
5.0
1.03
0.50
%
0.80
29
146
5
21
2.39
1.09
3.6
4.1
155.60
167.67
nmol/l
—
5
21
22
146
1.53
1.04
13.8
11.0
—
—
—
0
0
9
161
0.55
0.99
1.2
1.8
—
—
—
0
0
435
4514
0.84
0.95
40.1
16.4
27.02
26.84
mg/l
0.04
409
3734
47
367
1.31
0.93
3.2
3.2
—
—
—
0
0
11
63
1.76
0.90
1.1
1.3
65.68
51.77
mu/l
0.15
11
56
51
405
1.29
0.90
2.2
2.1
0.00
0.03
estimate
—
10
88
20
135
1.50
0.90
1.3
1.3
0.23
0.25
g/l
0.32
20
130
258
2395
1.14
0.84
5.2
3.5
0.00
0.00
estimate
-0.00
57
517
6
113
0.53
0.84
8.8
4.1
31.33
29.39
mg/l
—
6
90
8
46
1.75
0.83
1.3
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.7
—
—
—
0
0
55
451
1.24
0.77
4.7
5.0
1.31
0.81
%
0.60
26
157
11
67
1.65
0.75
2.4
2.7
—
—
—
0
0
262
2448
1.13
0.75
5.1
3.5
0.00
0.64
estimate
0.51
55
472
9
54
1.68
0.75
3.9
2.4
—
—
—
0
0
227
2105
1.13
0.73
18.5
12.1
0.00
0.00
e9/l
0.29
182
1742
260
2433
1.13
0.72
5.2
3.5
0.00
6.48
estimate
0.80
57
521
45
364
1.26
0.71
6.5
3.4
—
—
—
0
0
52
428
1.24
0.71
4.9
5.0
0.09
0.14
%
0.25
23
133
27
204
1.34
0.70
1.3
1.3
—
—
—
0
0
151
1368
1.14
0.69
4.2
3.0
380.83
364.10
umol/l
1.04
133
1226
12
77
1.57
0.69
3.8
3.5
3.58
4.51
e9/l
0.77
12
77
7
42
1.67
0.68
1.3
3.9
9.71
18.48
u/ml
—
7
42
7
43
1.64
0.67
1.1
1.1
—
—
—
0
0
12
78
1.55
0.66
6.0
3.9
7.63
10.21
pmol/l
0.51
12
78
11
70
1.58
0.65
1.5
1.7
3.55
5.16
mmol/24h
0.71
11
63
150
1366
1.13
0.64
5.3
3.5
0.00
0.01
estimate
0.78
55
460
5
30
1.67
0.61
1.2
1.9
—
—
—
0
0
8
50
1.61
0.61
1.5
1.3
—
—
—
0
0
8
50
1.61
0.61
1.3
1.1
—
—
—
0
0
24
183
1.33
0.60
2.1
4.8
43.98
41.95
mg/l
0.06
18
155
24
183
1.33
0.60
2.1
4.8
54.36
58.97
mg/l
0.14
18
153
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
28
221
1.28
0.56
2.3
2.3
0.00
3.54
estimate
—
8
71
6
38
1.59
0.54
2.7
3.3
17.27
15.82
%
—
6
38
6
39
1.54
0.53
2.7
3.1
6.98
8.24
mmol/l
—
6
39
6
40
1.51
0.51
1.8
1.4
—
—
—
0
0
7
45
1.56
0.49
1.1
1.1
0.17
0.19
nmol/l
—
7
35
41
346
1.20
0.48
3.5
2.3
6.00
6.02
ph
0.06
28
245
21
164
1.29
0.47
2.1
4.5
1.48
3.17
ratio
—
8
94
7
48
1.46
0.47
1.9
1.2
—
—
—
0
0
192
2038
0.91
0.46
2.1
2.0
1.44
1.40
mmol/l
0.28
166
1702
66
585
1.15
0.44
5.4
3.1
4.11
5.65
e9/l
0.92
56
514
7
51
1.38
0.44
2.3
1.8
—
—
—
0
0
5
32
1.57
0.42
1.2
1.0
907.60
645.68
ng/l
—
5
19
5
32
1.57
0.42
1.2
1.0
303.60
282.40
ng/l
—
5
20
8
57
1.41
0.42
1.1
2.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
0.27
—
0
5
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
84
764
1.12
0.39
1.3
1.3
27.89
33.93
iu/ml
0.23
17
236
22
179
1.24
0.38
1.3
1.2
—
—
—
0
0
11
147
0.74
0.37
1.8
1.1
0.93
0.91
g/l
0.15
11
147
14
107
1.32
0.37
4.1
3.4
54.62
56.93
%
0.26
14
107
13
99
1.32
0.35
1.2
1.1
—
—
—
0
0
49
435
1.14
0.34
5.1
5.3
0.05
0.15
%
0.52
20
122
22
182
1.22
0.33
3.3
4.0
274.00
203.52
mg/l
—
9
88
6
46
1.31
0.33
1.3
1.5
—
294.63
—
0
10
7
53
1.32
0.31
1.1
1.1
—
—
—
0
0
333
3241
1.07
0.30
4.4
3.8
14.83
14.87
pmol/l
0.08
307
2956
77
709
1.10
0.30
1.2
1.3
4.98
11.20
u/ml
0.75
24
286
7
57
1.23
0.29
2.7
1.3
—
—
—
0
0
174
1663
1.07
0.28
2.2
2.1
—
—
—
0
0
11
139
0.79
0.27
1.4
2.4
12.48
12.63
mg/l
0.03
11
130
14
113
1.25
0.27
5.4
3.9
—
—
—
0
0
44
486
0.90
0.25
1.7
1.5
—
—
—
0
0
190
1834
1.05
0.22
5.4
3.4
0.00
0.02
estimate
1.32
47
442
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
57.60
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
6.7
—
8.36
—
0
10
0
12
0.00
0.21
0.0
1.1
—
38.44
—
0
7
0
12
0.00
0.21
0.0
1.0
—
8.49
—
0
6
5
43
1.16
0.21
1.2
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
6
49
1.23
0.20
2.3
2.3
—
—
—
0
0
10
121
0.82
0.18
1.0
1.1
—
—
—
0
0
11
92
1.20
0.16
1.3
1.5
—
—
—
0
0
402
4068
0.96
0.15
5.7
4.6
2.03
1.96
mu/l
0.39
374
3721
127
1314
0.96
0.15
5.2
2.9
0.00
0.07
estimate
0.58
46
403
135
1310
1.04
0.13
1.4
1.4
—
—
—
0
0
26
239
1.09
0.12
1.0
1.1
—
—
—
0
0
59
618
0.95
0.11
1.4
1.3
—
—
—
0
0
22
239
0.92
0.10
1.8
3.0
—
—
—
0
0
105
1020
1.04
0.10
5.2
5.3
—
—
—
0
0
7
65
1.08
0.08
2.4
1.4
—
—
—
0
0
6
74
0.81
0.07
1.3
1.3
—
—
—
0
0
7
81
0.86
0.07
1.0
1.1
—
—
—
0
0
7
82
0.85
0.07
1.0
1.1
—
—
—
0
0
13
118
1.10
0.07
3.1
5.2
—
—
—
0
0
9
100
0.90
0.06
1.3
1.4
25.21
21.42
u/l
—
9
82
66
677
0.97
0.05
2.3
2.3
12.95
13.48
nmol/l
0.19
54
622
17
179
0.95
0.03
1.0
1.2
—
—
—
0
0
19
181
1.05
0.03
2.2
1.7
—
—
—
0
0
10
93
1.08
0.02
2.9
1.9
3.02
5.54
iu/l
—
5
33
21
216
0.97
0.00
1.3
1.2
14.34
157.87
u/ml
—
8
83
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.8
—
43.60
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
-0.00
2.9
3.0
0.87
1.26
g/24h
—
7
45
0
6
0.00
-0.00
0.0
3.5
—
0.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
14.86
—
0
7
0
8
0.00
-0.00
0.0
1.3
—
114.00
—
0
8
0
5
0.00
-0.00
0.0
2.8
—
0.82
—
0
5
0
5
0.00
-0.00
0.0
9.6
—
9.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
2.14
—
0
5
0
7
0.00
-0.00
0.0
4.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ALCGASTR and mortality.

Females

Parameter HR [95% CI] p-value
K11_ALCGASTR 4.498 [3.58, 5.65] < 0.001
Birth year 0.993 [0.98, 1.0] 0.133

During the follow-up period (1.1.1998 — 31.12.2019), 319 out of 811 females with K11_ALCGASTR died.

Males

Parameter HR [95% CI] p-value
K11_ALCGASTR 5.276 [4.73, 5.89] < 0.001
Birth year 0.985 [0.98, 0.99] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1583 out of 3301 males with K11_ALCGASTR died.

Mortality risk

Mortality risk for people of age

years, who have K11_ALCGASTR.

N-year risk Females Males
1 0.401% 1.047%
5 2.604% 5.565%
10 5.726% 13.663%
15 11.178% 24.839%
20 19.69% 39.977%

Relationships between endpoints

↥

Index endpoint: K11_ALCGASTR – Alcoholic gastritis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data